col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


495 Results       Page 1

 [1] 
Wiley: Journal of the European Academy of Dermatology and Venereology
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―28 Skin manifestations of SARS-CoV-2 Omicron variant: Clinical, pathological, and immunological insights Yuling Zhang, Yueming Mu, Bing Han, Rowida A. Albarmaqi, Huimin Wang, Yuemeng Zhao, et al. (+7)
2 [GO] 2024―Mar―21 Flares and new related lesions of Hidradenitis Suppurativa following COVID-19 vaccination: A retrospective cohort study of 250 patients in Greece Aikaterini I. Liakou, Andreas G. Tsantes, Magdalini Kalamata, Lydia Tsamtsouri, Efthymia Agiasofitou, Soultana Vladeni, et al. (+7)
3 [GO] 2024―Mar―18 The role of COVID-19 vaccines in the development and recurrence of pemphigus and bullous pemphigoid Gaurav N. Pathak, Anurag N. Pathak, Babar Rao
4 [GO] 2024―Feb―24 The impact of COVID-19 pandemic on the number of first diagnosis and follow-up visits of patients affected by pemphigus, bullous pemphigoid, scleroderma, psoriasis and vitiligo: A single-centre experience Francesco Moro, Feliciana Mariotti, Anna Pira, Luciano Sobrino, Sabatino Pallotta, Annarita Panebianco, Giovanni Di Zenzo
5 [GO] 2024―Feb―21 A sharp increase in early syphilis cases in a referral hospital in Athens, Greece, 2 years into the COVID-19 pandemic E. Nicolaidou, K. Fouseki, V. Paparizos, O. Kotsafti, V. Vasalou, E. Daskalakis, et al. (+11)
6 [GO] 2024―Feb―01 Annular cutaneous sarcoidosis following COVID-19 vaccination José Ramos, António Silva, Ângela Roda, João Alves
7 [GO] 2024―Jan―13 De novo pemphigus vulgaris and pemphigus foliaceus development following COVID-19 infection and vaccination: Matched case-control study P. G. Arduino, A. A. Kubanov, A. V. Vlasova, A. A. Martynov, S. I. Svishchenko, S. Petti
8 [GO] 2023―Dec―23 Addressing Th1/17-associated immune dysfunction in psoriasis patients enhances the effectiveness of the inactivated SARS-CoV-2 vaccine Chao Ji, Yihua Zhang, Li Li, Shi-Fan Ruan, Liangqi Cai, Kunli Zhou, et al. (+12)
9 [GO] 2023―Dec―18 Attitudes towards clinical research in adult patients with hidradenitis suppurativa during the COVID-19 pandemic: Insights from a survey Nikolaj Holgersen, Valdemar W. Nielsen, Zarqa Ali, Mette Brøgger-Mikkelsen, Marius M. Flege, Jacob P. Thyssen, et al. (+2)
10 [GO] 2023―Dec―14 Secondary livedoid vasculopathy following SARS-CoV-2 infection A. M. Carballido Vázquez, T. L. Vega López, P. Manchado López, G. Martínez García, A. Mateos Mayo
11 [GO] 2023―Dec―09 Reply to ‘New onset of systemic lupus erythematosus following COVID-19 mRNA vaccination’ E. Magnaterra, E. B. Mariotti, A. Corrà, C. Aimo, L. Quintarelli, V. Ruffo di Calabria, et al. (+2)
12 [GO] 2023―Nov―01 Cutaneous Tuberculosis and its possible association with COVID-19 Neerja Saraswat, Durga Madhab Tripathy, Abhishek Mishra, Sushil Kumar, Shobhit Goel
13 [GO] 2023―Nov―01 Reactive Infectious Mucocutaneous Eruption (RIME) secondary to COVID-19 infection: A Case Report and Review of the literature Georgia Koroneos, William Berry, Nicola Sweeney, Vanessa Morgan, Nur-Shirin Harun, Jenny Nicolopoulos
14 [GO] 2023―Oct―05 Lichen planus pemphigoides after COVID-19 infection D. Didona, A. M. Sequeira-Santos, J. Hinterseher, T. Cunha, M. Hertl
15 [GO] 2023―Sep―15 New onset of systemic lupus erythematosus following COVID-19 mRNA vaccination E. Hansen, R. Feldmann, R. Pirker, J. Jochmann, F. Breier, C. Posch
16 [GO] 2023―Sep―14 The Gabrin Sign's Potential for Identifying High-Risk Patients for COVID-19 with Androgenic Alopecia Alpana Mohta, Sumiti Pareek, Vijeta Prasad, Achala Mohta, Asha Nyati
17 [GO] 2023―Aug―23 Aquagenic keratoderma as a consequence of excessive handwashing during the COVID-19 pandemic-A case report Raquel Falcão de Freitas, António Freitas
18 [GO] 2023―Aug―23 Ulcerating reaction in association with Pfizer-BioNTech COVID-19 vaccine in an 11-year-old boy Justin Thrush, Samantha Polly, John Anthony, James Fernandez, James Taylor, DeVon C. Preston, Anthony P. Fernandez
19 [GO] 2023―Aug―19 A case of COVID-19-associated generalized indeterminate cell histiocytosis successfully treated with systemic PUVA Finn Abeck, Justus Vehring, Domenica Varwig-Janßen, Anne Menz, Maria Christolouka, Stefan W. Schneider
20 [GO] 2023―Aug―10 A case of generalized pustular psoriasis complicated by acute respiratory distress syndrome after COVID-19 vaccination Ayaka Itami, Tomomitsu Miyagaki, Shuhei Mitsuishi, Akihiro Horie, Tatsuro Okano, Sora Takeuchi, et al. (+2)
21 [GO] 2023―Aug―10 A severe relapse of Pemphigus Vulgaris after SARS-CoV-2 vaccination. L. Ligrone, S. Lembo, F. Cillo, S. Spennato, G. Fabbrocini, A. Raimondo
22 [GO] 2023―Jul―20 Bullous pemphigoid with autoantibodies against full-length BP180 protein after COVID-19 infection Kazumasa Oya, Masakazu Kakurai, Kentaro Izumi, Norito Ishii, Toshifumi Nomura
23 [GO] 2023―Jul―17 Gianotti-Crosti syndrome following Covid-19 infection M. Ben Kahla, J. Rouatbi, N. Ghariani Fetoui, A. Aounallah, B. Sriha, C. Belajouza, et al. (+4)
24 [GO] 2023―Jul―07 Schnitzler syndrome associated with recurrent subacute thyroiditis and SARS-CoV-2 vaccine - a case review K. Kanabaj, M. Sokołowska-Wojdyło, A. Wilkowska, R. J. Nowicki
25 [GO] 2023―Jun―28 Papuloerythroderma of Ofuji following COVID-19 vaccination Yu-Wen Huang, Wen-Hung Chung, Chun-Bing Chen
26 [GO] 2023―Jun―20 A case of recurrence of pyoderma gangrenosum after Covid-19 vaccine L. Bettolini, S. Bighetti, S. Mezzana, A. Gelmetti, P. Calzavara-Pinton, V. Maione
27 [GO] 2023―Jun―17 New-onset pemphigus vulgaris and pemphigus foliaceus following COVID-19 infection and vaccination, systematic review of case reports and a causal hypothesis S. Petti, P. G. Arduino
28 [GO] 2023―Jun―16 Clinical and epidemiological features of psoriasis exacerbations in children with SARS-CoV-2 infection S. Skrek, V. Di Lernia, A. Beauchet, A.-C. Bursztejn, A. Belloni Fortina, A. Lesiak, et al. (+21)
29 [GO] 2023―Jun―16 Comment on: “Clinical characteristics of patients with pityriasis rubra pilaris following SARS-CoV-2 vaccination” by Gambichler. Luca Potestio, Fabrizio Martora, Alessia Villani, Matteo Megna, Angelo Ruggiero
30 [GO] 2023―Jun―09 Impact of COVID-19 in patients with autoimmune bullous diseases: report from an international registry Joost M. Meijer, Hanan Rashid, Styliani Vergadi, Emiliano Antiga, Pamela Vezzoli, Riccardo Balestri, et al. (+19)
31 [GO] 2023―May―17 A case of Covid-19-related vulval ulceration coupled with genital viral shedding E. Mastoraki, S. Niforatou-Daskalaki, C. B. Bunker, G. Kravvas
32 [GO] 2023―May―12 Corrigendum: Impact of SARS-CoV -2 infection in children with psoriasis: Results of a monocentric experience
33 [GO] 2023―Apr―28 SARS-CoV-2 vaccination may trigger and exacerbate mucosal lichen planus A. Dangien, D. Darbord, J. Chanal, J. Wendling, C. Pantoja, B. Oules, et al. (+12)
34 [GO] 2023―Apr―28 Exacerbation of Acquired Perforating Dermatosis Following SARS-CoV-2 Vaccination Nadia Sciamarrelli, Niccolò Siliquini, Luca Mastorino, Rebecca Senetta, Paolo Dapavo, Simone Ribero, Pietro Quaglino
35 [GO] 2023―Apr―27 SARS-CoV -2 infection associated with severe oral, conjunctival and genital lesions (Fuchs syndrome) N. Ganjuur, D. F. D’Urso, G. M. Girbig, N. Booken, M. Augustin
36 [GO] 2023―Apr―15 Acute generalized exanthematous pustulosis (AGEP) in a patient with COVID-19 infection L. De Brucker, L. Seyler, G. Leemans, J. Gutermuth, M. Grosber
37 [GO] 2023―Apr―05 VEXAS syndrome following COVID-19 mRNA vaccination François Skowron, Lucas Klepfisch, Laurent Guillaume, Janique Godeneche, Anthony Facile, Martin Gombert, et al. (+2)
38 [GO] 2023―Apr―05 Leprosy reactions after SARS-COV2 (COVID-19) infection I. M. Gutiérrez-Villarreal, J. Ocampo-Candiani, A. Villarreal-Martinez, M. Gomez-Flores, L. T. Fernández, G. Rodríguez-Tamez, et al. (+4)
39 [GO] 2023―Apr―05 Erythema multiforme major associated with molnupiravir treatment for SARS-CoV-2 infection: first report Corrado Zengarini, Vito Epifani, Carlotta Baraldi, Martina Mussi, Luciano Potena, Laura Giovannini, Alessandro Pileri
40 [GO] 2023―Apr―05 Delay in the diagnosis and management of suspicious malignant skin lesions during the COVID -19 pandemic in a reference center in Mexico Eduardo Corona-Rodarte, Antonio Olivas-Martinez, Rodrigo Solis-Pompa, Luis Enrique Cano-Aguilar, Daniel Asz-Sigall, María del Rocío Ferrusco-Ontiveros, et al. (+2)
41 [GO] 2023―Mar―14 SARS-CoV -2 vaccination status and adverse events among patients with psoriasis - data from the German Registries PsoBest and CoronaBest M. Valencia López, A. Meineke, B. Stephan, S. Rustenbach, A. Kis, D. Thaci, et al. (+6)
42 [GO] 2023―Mar―14 Clinical characteristics of patients with pityriasis rubra pilaris following SARS-CoV-2 vaccination Thilo Gambichler
43 [GO] 2023―Mar―13 Sweet Syndrome following SARS-CoV -2 infection: a unique bullous photo-distributed presentation Cláudia Brazão, Dora Mancha, Luís Soares-de-Almeida, Paulo Filipe
44 [GO] 2023―Mar―13 Humoral and cellular immune responses to repeated SARS-CoV-2 infection and vaccination in an individual living with HIV A. Simsek, C. Bessen, T. L. Meister, D. Urlaub, A. Skaletz-Rorowski, N. H. Brockmeyer, et al. (+8)
45 [GO] 2023―Mar―08 Telogen Effluvium in SARS-CoV -2 Infection: histological aspects S. Michelini, G. Caro, M. Di Fraia, M. Fortuna, F. Magri, V. V. Gomes, et al. (+4)
46 [GO] 2023―Feb―25 Impact of COVID -19 pandemic on acute Dermatology referrals in a secondary and tertiary care Central London Hospital. A retrospective comparison review of pre-COVID -19 era and COVID -19 pandemic E. Panagou, E. Panou, J. Crawley, O. Veraitch, E. V. Edmonds, C. B. Bunker, C. L. Martyn-Simmons
47 [GO] 2023―Feb―18 Excess Psoriasis and Psoriatic Arthritis Mortality During the COVID -19 Pandemic in the United States: A Nationwide Population-Based Study from 2010-2021 Ying Liu, Xinyuan He, Ernest Y. Lee, Fan Lv, Leiqing Yao, Qinqin Meng, et al. (+7)
48 [GO] 2023―Feb―14 Covid-19-associated chilblain pruritus is non-histaminergic mediated and correlated to epidermal interleukin 31 Angelina Labib, Leigh Nattkemper, Ashley Vander Does, Teresa Ju, Sara Cacciapuoti, Maria Vastarella, et al. (+2)
49 [GO] 2023―Feb―14 Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV -2 in patients with pemphigus and bullous pemphigoid F. Solimani, A. Mesas-Fernandez, E. Bodner, M. Carevic-Neri, M. Hasheminasab, T. Jakovljevicova, et al. (+6)
50 [GO] 2023―Feb―14 The impact of the COVID -19 pandemic on the diagnosis of cutaneous melanomas; a retrospective cohort study from five European skin cancer reference centers Alexander Troesch, Magdalena Hoellwerth, Stephan Forchhammer, Laura Del Regno, Georg Lodde, Patrick Turko, et al. (+9)
51 [GO] 2023―Feb―03 Heterologous Vs homologous primary and booster COVID-19 vaccination do not increase flare rate in patients with psoriasis and/or psoriatic arthritis: insights from a real-life, multicenter, case-control study Santo Raffaele Mercuri, Alessia Pacifico, Piergiorgio Malagoli, Vittoria Giulia Bianchi, Fabrizio Ernesto Pregliasco, Massimo Del Fabbro, Giovanni Damiani
52 [GO] 2023―Jan―22 Reply to: ‘Severe bullous pemphigoid following Covid-19 vaccination resistant to rituximab and successfully treated with dupilumab’ by Baffa et al L. Sun, C. Brazão, D. Mancha, L. Soares-de-Almeida, P. Filipe
53 [GO] 2023―Jan―20 Risk-benefit profiles associated with receiving Moderna COVID-19 (mRNA-1273) vaccine as an additional pre-booster dose in immune-mediated dermatologic disease patients with low SARS-CoV-2-specific immunity following the primary series: a prospective cohort study C. Seree-aphinan, P. Suchonwanit, P. Rattanakaemakorn, C. Pomsoong, Y. Ratanapokasatit, C. Setthaudom, et al. (+2)
54 [GO] 2023―Jan―20 Study of covid-19 vaccine related cutaneous adverse events following immunization and establishing causal association Rohini Sharma
55 [GO] 2023―Jan―17 Impact of SARS-CoV-2 infection in children with psoriasis: results of a monocentric experience Francesca Caroppo, Laura Fagotto, Jacopo Tartaglia, Roberto Mazzetto, Anna Belloni Fortina
56 [GO] 2023―Jan―16 Dupilumab treatment for severe atopic dermatitis in children and SARS-CoV2 infection: a combination of triggers for psoriasis C. Colonna, P. Bortoluzzi, R. Cavalli
57 [GO] 2023―Jan―06 Epidermal necrolysis after COVID-19 vaccination: An exploratory analysis using World Health Organization VigiBase B. Ahouach, E. Diaz, B. Bertin, B. Ben Said, S. Combret, A. Grandvuillemin, et al. (+6)
58 [GO] 2023―Jan―06 Multispectral optoacoustic tomography to differentiate between lymph node metastases and coronavirus-19 vaccine-associated lymphadenopathy J.-M. Placke, D. Mertens, A. Tasdogan, E. Chorti, D. Schadendorf, S. Ugurel, et al. (+3)
59 [GO] 2022―Dec―14 New insights on acral peeling dermatoses: an overlooked skin manifestation during COVID-19 pandemic Iria Neri, Alba Guglielmo, Annalucia Virdi, Miriam Leuzzi, Bianca Maria Piraccini, Marco Adriano Chessa
60 [GO] 2022―Dec―05 Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV -2 vaccination: a multicentre experience from tertiary referral hospitals G. Avallone, C. A. Maronese, C. Conforti, P. Fava, L. Gargiulo, A. V. Marzano, et al. (+13)
61 [GO] 2022―Nov―28 Capillaritis as cutaneous adverse reaction to SARS-CoV -2 primary and booster vaccination: A series of eight cases Luca Di Bartolomeo, Federico Vaccaro, Francesco Borgia, Maria Lentini, Caterina Longo, Mario Vaccaro
62 [GO] 2022―Nov―22 Pityriasis rubra pilaris following inactivated SARS-CoV -2 vaccine ( CoronaVac ) Li-wen Zhang, Wen-ju Wang, Li-xin Fu, Yong-hong Lu, Tao Chen, Rong-hua Xu
63 [GO] 2022―Nov―17 Lichen planus after COVID-19 infection and vaccination: a systematic review Betty Nguyen, Alexandra G. Perez, George W. Elgart, Scott A. Elman
64 [GO] 2022―Nov―15 COVID-19 vaccine-induced Sweet syndrome presenting as fingertip pustules Subhajit Sadhukhan, Sahiba Rafi, Anupama Bains, Divya Aggarwal
65 [GO] 2022―Oct―21 A cross-sectional study of dermatologists’ attitudes toward COVID-19 vaccination in patients with immunobullous diseases M. Kasperkiewicz, R. Strong, M. Yale, P. Dunn, D. T. Woodley
66 [GO] 2022―Oct―21 Severe bullous pemphigoid following Covid-19 vaccination resistant to rituximab and successfully treated with dupilumab M. E. Baffa, R. Maglie, F. Montefusco, C. Pipitò, S. Senatore, E. Antiga
67 [GO] 2022―Sep―27 Anaplastic large cell lymphoma at the SARS-CoV2 vaccine injection site. L. Revenga-Porcel, Y. Peñate, F. Granados-Pacheco
68 [GO] 2022―Sep―23 Course and outcome of chilblain-like acral lesions during COVID-19 pandemic K. Blau, S. Lehr, R. Aschoff, S. Al Gburi, N. Brück, M. Chapsa, et al. (+5)
69 [GO] 2022―Sep―23 Regression of common viral warts in an immunocompetent child and an immunosuppressed adult relative after mRNA BNT162b2 COVID-19 vaccine Maria Dalamaga, Dimitrios Tsilingiris, Alexandros Katoulis
70 [GO] 2022―Aug―22 COVID-19 induced pityriasis rubra pilaris: a superantigenic disease? Italo Francesco Aromolo, Armando Pisapia, Davide Riva, Francesco Barberi, Angelo Valerio Marzano, Chiara Moltrasio, Maurizio Romagnuolo
71 [GO] 2022―Aug―22 Reply to A. Ruggiero et Al . to our article “Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity” R. Molinier, A. Roger, B. Genet, P. Saiag, E. Funck-Brentano
72 [GO] 2022―Aug―22 The effects of COVID -19 pandemic on malignant melanoma diagnosis Alessia Villani, Massimiliano Scalvenzi, Gabriella Fabbrocini, Luigi Fornaro, Gianluca Guerrasio, Luca Potestio
73 [GO] 2022―Aug―22 Despite the use of ivermectin during the COVID pandemic, scabies keeps playing tricks with us Juliana Polizel Ocanha Xavier, José Cândido Caldeira Xavier-Jr
74 [GO] 2022―Aug―22 Rituximab in immunobullous disorders during the COVID -19 pandemic: a systematic review of observational studies M. Kasperkiewicz, D. T. Woodley
75 [GO] 2022―Aug―20 Authors’ reply to comment by Ciccarese et al . regarding “Negative SARS-CoV -2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions” E. Welsh, J. A. Cardenas-de la Garza, E. Brussolo-Marroquín, A. Cuellar-Barboza, R. Franco-Marquez, Gerardo Ramos-Montañez
76 [GO] 2022―Aug―17 Comment on “Negative SARS-CoV-2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions” G. Ciccarese, F. Broccolo, A. Parodi, F. Drago
77 [GO] 2022―Aug―16 Safe delivery of systemic anti-cancer treatment for skin cancers during the COVID-19 pandemic M. J. Monroy-Iglesias, H. Hadi, B. Russell, C. Moss, L. Flanders, S. Dolly, et al. (+2)
78 [GO] 2022―Aug―16 Reply to “Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity” by R. Molinier et al. Angelo Ruggiero, Fabrizio Martora, Fabrizio Fornaro, Massimiliano Scalvenzi, Gabriella Fabbrocini, Alessia Villani
79 [GO] 2022―Aug―16 Skin reaction after Sars-Cov-2 vaccines Reply to ‘Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experience’ Fabrizio Martora, Alessia Villani, Claudio Marasca, Gabriella Fabbrocini, Luca Potestio
80 [GO] 2022―Aug―14 Authors’ reply to: “Generalized pustular figurate erythema first report in two COVID-19 patients on hydroxychloroquine” M. Bertello, G. Rubegni, P. Rubegni, L. Tognetti
81 [GO] 2022―Aug―14 New onset pemphigus foliaceus following AstraZeneca COVID-19 vaccination M. Almasi-Nasrabadi, R. S. Ayyalaraju, A. Sharma, S. Elsheikh, S. Ayob
82 [GO] 2022―Aug―14 Safety of the COVID-19 vaccine booster in patients with immunobullous diseases: a cross-sectional study of the International Pemphigus and Pemphigoid Foundation M. Kasperkiewicz, R. Strong, M. Yale, P. Dunn, D. T. Woodley
83 [GO] 2022―Aug―14 Association of Interstitial Granulomatous Dermatitis with Messenger Rna-1273 Sars-Cov-2 Vaccine C. Ariasi, G. Perazzolli, A. Gelmetti, S. Battocchio, P. G. Calzavara-Pinton
84 [GO] 2022―Aug―11 Alopecia areata after COVID-19 infection and vaccination: a cross-sectional analysis Betty Nguyen, Antonella Tosti
85 [GO] 2022―Jul―16 Pityriasis lichenoides chronica after BNT162B2 Pfizer-BioNTech vaccine: A novel cutaneous reaction after SARS-CoV -2 vaccine F Drago, G Ciccarese, A Guadagno, A Parodi
86 [GO] 2022―Jul―05 Reply to “Development of severe pemphigus vulgaris following SARS-CoV -2 vaccination with BNT162b2 ” by Solimani F et al. Francesca Falcinelli, Arianna Lamberti, Carlo Cota, Pietro Rubegni, Elisa Cinotti
87 [GO] 2022―Jun―30 Influence of Covid-19 vaccination on immune-mediated skin diseases Narjes A Alelq, Michaela E Kubieniec, Lars E French, Jörg C Prinz
88 [GO] 2022―Jun―30 Pyoderma gangrenosum after mRNA -based SARS-CoV -2 vaccine J. Franceschi, AS. Darrigade, P. Sanchez-Pena, V. Legrain-Lifermann, B. Milpied
89 [GO] 2022―Jun―30 Cutaneous adverse reaction following SARS-CoV -2 vaccine booster dose: a real-life multicentre experience G Avallone, F Cavallo, C Astrua, G Caldarola, C Conforti, C De Simone, et al. (+12)
90 [GO] 2022―Jun―29 A spectrum of leprosy reactions triggered by Covid-19 vaccination: a series of four cases N. Saraswat, D. M. Tripathy, S. Kumar, P. Awasthi, M. M. Gopal
91 [GO] 2022―Jun―24 Types and Prevalence of Adverse Skin Reactions Associated With Prolonged N95 and Simple Mask Usage during the COVID -19 Pandemic Ariel R. Darnall, Dana Sall, Curt Bay
92 [GO] 2022―Jun―20 Long-term effects of the COVID-19 pandemic on malignant melanoma: increased lymph node metastases in two German dermatology clinics Galina Balakirski, Alena-Lioba Michalowitz, Alexander Kreuter, Silke C. Hofmann
93 [GO] 2022―Jun―20 Ultrastructural evidence for anagen hair follicle infection with SARS-CoV -2 in early-onset COVID -19 effluvium I.F.S. Mazeto, C.C. Brommonschenkel, A.C. Miola, P. Müller Ramos, D. Carvalho dos Santos, H.A. Miot
94 [GO] 2022―Jun―20 Sweet Syndrome following SARS-CoV-2 CoronaVac vaccine Nesrine Ben Salah, Mouna Korbi, Najeh Ben Fadhel, Idoudi Safa, Ferdaous Chad, Manel Njima, et al. (+4)
95 [GO] 2022―Jun―20 Maternal SARS-CoV-2 infection and aplasia cutis congenita in a newborn Yan Jiang, Xue Yu, Ming-Gang Deng, Chun-Xiang Wu, Xiao-Yu Xu, Ting Luo, Zhi-Jiang Zhang
96 [GO] 2022―Jun―17 From COVID-19 to war - life of a dermatological journal in times of crisis J. Ring
97 [GO] 2022―Jun―10 Erythema nodosum following SARS-CoV -2 vaccine Yihang Xie, Bin Yin, Xin Shi
98 [GO] 2022―Jun―10 Hansen's disease case detection in Brazil: a backlog of undiagnosed cases due to COVID -19 pandemic P. Deps, S. M. Collin, V. L. Gomes de Andrade
99 [GO] 2022―Jun―10 New onset of sarcoidosis after COVID-19 infection Andrea Rabufetti, Luca Borradori, Kristine Heidemeyer, Laurence Feldmeyer, Robert E. Hunger, Nikhil Yawalkar, S. Morteza Seyed Jafari
100 [GO] 2022―Jun―09 Reply to ‘Development of severe pemphigus vulgaris following SARS-CoV -2 vaccination with BNT162b2 ’ by Solimani et al M. Fabrizio, F. Gabriella, P. Nappa, M. Matteo
101 [GO] 2022―Jun―06 Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: A systematic review and meta-analysis C. Washrawirul, J. Triwatcharikorn, J. Phannajit, M. Ullman, P. Susantitaphong, P. Rerknimitr
102 [GO] 2022―May―26 A case of pityriasis lichenoides et varioliformis acuta (PLEVA) developed after first dose of Oxford-AstraZeneca COVID-19 vaccine Federica Filippi, Carlotta Baraldi, Pier Luigi Zinzani, Beatrice Casadei, Alessandro Pileri
103 [GO] 2022―May―23 Efficacy of low-dose methotrexate in a short-regimen for granulomatous sarcoid-like reaction on permanent make-up during COVID-19 infection Nicolas Kluger, Vincent Descamps
104 [GO] 2022―May―23 Maskne prevalence and risk factors during the COVID-19 pandemic Alessia Villani, Gabriella Fabbrocini, Maria Carmela Annunziata, Luca Potestio
105 [GO] 2022―May―23 Nail psoriasis: a rare mRNA COVID-19 vaccine reaction A. Lamberti, V. Lora, D. Graceffa, C. Bonifati, C. Cota
106 [GO] 2022―May―23 Generalized morphea after COVID-19 vaccines: a case series G Paolino, C Campochiaro, MR Di Nicola, SR Mercuri, N Rizzo, L Dagna, et al. (+2)
107 [GO] 2022―May―23 Urticarial vasculitis triggered by SARS-CoV-2 vaccine (mRNA vaccine) M Daldoul, M Korbi, A Bellalah, N Ben Fadhel, H Belhadjali, J Zili
108 [GO] 2022―May―16 Impact of the Covid-19 pandemic on Melanoma and Non-melanoma skin cancer inpatient treatment in Germany - a nationwide analysis Johannes Kleemann, Markus Meissner, Deniz Özistanbullu, Ümniye Balaban, Oliver Old, Stefan Kippenberger, et al. (+4)
109 [GO] 2022―May―11 Effects of wearing personal protective equipment during COVID-19 pandemic on composition and diversity of skin bacteria and fungi of medical workers X. Lin, Y.Z. Li, T. Chen, S.H. Min, D.F. Wang, M.M. Ding, G. Jiang
110 [GO] 2022―May―10 Erythrodermic pityriasis rubra pilaris after SASRS-CoV-2 vaccination with concomitant COVID-19 infection T. Gambichler, C.H. Scheel, Y. Arafat, O. Kautz, S. Boms
111 [GO] 2022―May―10 A case of onychomadesis associated to chilblain-like lesions after COVID-19 infection Cristiana Colonna, Serena Giacalone, Martina Zussino, Nicola Adriano Monzani, Stefano Cambiaghi, Riccardo Cavalli
112 [GO] 2022―May―10 Reactive infectious mucocutaneous eruption triggered by COVID-19 infection in an adult patient Elena Gimeno, Daniel Morgado-Carrasco, David Moriscot, Jaime Piquero-Casals
113 [GO] 2022―May―10 Association between COVID-19 vaccination and autoimmune bullous diseases: a random coincidence or rare event Michael Kasperkiewicz
114 [GO] 2022―May―10 Development of delayed dermal hypersensitivity reaction following the second dose of COVID-19 vaccine- a series of 37 cases Alpana Mohta, Manoj Kumar Sharma
115 [GO] 2022―May―10 Onset of amyopathic dermatomyositis following mRNA-based SARS-CoV-2 vaccination Alexander Kreuter, Sara Lausch, Sven-Niklas Burmann, Alexandros Paschos, Alena-Lioba Michalowitz
116 [GO] 2022―May―10 Allergic reaction to Red Cosmetic lip tattoo with possible exacerbations after SARS-CoV-2 vaccination Nicolas Kluger
117 [GO] 2022―Apr―26 Role of the International Pemphigus and Pemphigoid Foundation during the COVID-19 pandemic M. Kasperkiewicz, R. Strong, M. Yale, P. Dunn, D. T. Woodley
118 [GO] 2022―Apr―26 Negative SARS-CoV -2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions E. Welsh, J. A. Cardenas-de la Garza, E. Brussolo-Marroquín, A. Cuellar-Barboza, R. Franco-Marquez, Gerardo Ramos-Montañez
119 [GO] 2022―Apr―16 Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire based study Jai Bawane, Rajesh Kataria, Anil Mohite, Kapila Verma, Utkarsh Shukla
120 [GO] 2022―Apr―16 Disseminated herpes zoster in an immune-competent patient after SARS-CoV -2 Vaccine ( BNT162b2 Comirnaty, Pfizer) Corrado Zengarini, Cosimo Misciali, Tiziano Ferrari, Emi Dika, Michelangelo La Placa, Bianca Maria Piraccini, Carlotta Baraldi
121 [GO] 2022―Apr―16 SARS-CoV-2 mRNA booster vaccine-associated lichenoid drug eruption Dillon Mintoff, David Pisani, Nevise Livori, Ian Said-Huntingford, Godfrey Baldacchino
122 [GO] 2022―Apr―10 Hemorrhagic bullous pyoderma gangrenosum following COVID-19 vaccination Yi-Teng Hung, Wen-Hung Chung, Tsung-Fu Tsai, Chun-Bing Chen
123 [GO] 2022―Mar―30 Commentary on “Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine” Dursun Turkmen, Nihal Altunisik
124 [GO] 2022―Mar―30 Autoimmune bullous dermatoses associated with COVID-19 outbreak in Russian patients: a single case series A. Lepekhova, E. Grekova, O. Olisova, E. Dunaeva, S. Ahmed, I. Maximov, N. Teplyuk
125 [GO] 2022―Mar―30 A rare case of reactive granulomatous dermatitis during COVID-19: a possible role of cephalosporine and potential mechanisms A. Aoki, M. Yamane, Y. Aoyama
126 [GO] 2022―Mar―29 De novo annular pustular psoriasis following mRNA COVID-19 vaccine M. Romagnuolo, P. Pontini, S. Muratori, A. V. Marzano, C. Moltrasio
127 [GO] 2022―Mar―28 Symmetrical drug-related intertriginous and flexural exanthema like eruption after COVID-19 vaccine Ines Lahouel, Nesrine Ben Salah, Najeh Ben Fadhel, Ferdaous Chahed, Nourelimene Ouni, Hichem Belhadjali, et al. (+2)
128 [GO] 2022―Mar―19 Covid-19 and Covid-19 vaccine can slide along sides: a report of two cases of unilateral periflexural exanthem Andrea Sechi, Andrea Bassi, Carlo Mazzatenta, Mario Cutrone, Luigi Naldi, Giuseppe Argenziano, Vincenzo Piccolo
129 [GO] 2022―Mar―19 Transient inflammation in surgical scars following Covid-19 mRNA vaccination C. Ferreli, J. Anedda, L. Atzori L
130 [GO] 2022―Mar―12 Maskne prevalence and associated factors in Irish healthcare workers during the COVID-19 pandemic L.F. Kiely, C. O'Connor, G. O’Briain, C. O’Briain, J. Gallagher, J.F. Bourke
131 [GO] 2022―Mar―12 Pityriasis rubra pilaris (type I) following ChAdOx1 COVID-19 vaccine: A report of two cases with successful treatment with oral isotretinoin P.R. Criado, M. Ianhez, P.S. Rocha, H.A. Miot
132 [GO] 2022―Mar―12 Case of lichen planus pigmentosus-inversus after Oxford-AstraZeneca COVID-19 vaccine: cause or coincidence? L. Sun, S. Duarte, L. Soares-de-Almeida
133 [GO] 2022―Mar―12 Primary cutaneous lymphoma and risk for severe COVID-19: a prospective study of 48 cases in Morocco H. Kerrouch, M. Khalidi, R. Frikh, N. Hjira, M. Boui
134 [GO] 2022―Mar―12 Healthcare and safety of patients with melanoma during the COVID-19 Pandemic in Italy S. Caini, M. Brusasco, G. Niero, V. De Giorgi, M. Lombardo, C. Massone, et al. (+8)
135 [GO] 2022―Mar―11 Erythema Multiforme in COVID-19 Patients and Following COVID-19 Vaccination: Manifestations, Associations, and Outcomes Farshid Etaee, Mohamadmehdi Eftekharian, Tarek Naguib, Steven Daveluy
136 [GO] 2022―Mar―11 Prevalence and patterns of cutaneous manifestations in 1,245 COVID-19 patients in Japan: a single-centre study T. Sugai, Y. Fujita, E. Inamura, Y. Maya, S. Shimizu
137 [GO] 2022―Mar―11 Another case of generalized bullous fixed drug eruption following an adenoviral-vector based Covid-19 vaccine (ChAdOx1 nCov-19) Chaker Ben Salem, Abdelmajid Khelif, Dhouha Sahnoun, Nadia Ghariani, Badreddine Sriha, Mohamed Denguezli
138 [GO] 2022―Mar―11 Two cases of anti-TIF1-γ antibody positive dermatomyositis with manifested symptoms after SARS-CoV-19 vaccination A Yoshida, T Ikegami, K Igawa
139 [GO] 2022―Feb―28 Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID-19 vaccine, successfully treated with risankizumab G. Pavia, L. Gargiulo, F. Spinelli, J. Avagliano, M. Valenti, R. G. Borroni, et al. (+2)
140 [GO] 2022―Feb―28 Erythema Nodosum Leprosum Post-COVID-19 Vaccination: Endemic while Pandemic Tahel Fachler, Karen Olshtain-Pops, Liran Horev
141 [GO] 2022―Feb―27 Association between vaccination and immunobullous disorders: A brief, updated systematic review with focus on COVID-19 Michael Kasperkiewicz, David T. Woodley
142 [GO] 2022―Feb―20 Pityriasis lichenoides et varioliformis acuta after SARS-CoV-2 infection and relapse after vaccination Tuomas Mäkilä, Leila Jeskanen, Mariia Butina, Liisa Harjama, Annamari Ranki, Tarja Mälkönen, Nicolas Kluger
143 [GO] 2022―Feb―17 A case of psoriatic spondyloarthritis exacerbation triggered by COVID-19 messenger RNA vaccine Shin-ichiro Ohmura, Shiho Hanai, Ryuhei Ishihara, Yusuke Ohkubo, Toshiaki Miyamoto
144 [GO] 2022―Feb―17 Reply to “Dermatoses caused by face mask wearing during the COVID-19 pandemic Federico Bardazzi, Lidia Sacchelli, Camilla Loi, Federica Filippi, Alba Guglielmo
145 [GO] 2022―Feb―17 Unilateral linear purpuric rash heralding SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia Yi-Teng Hung, Yen-Lin Huang, Yao-Yu Chang, Wei-Ti Chen
146 [GO] 2022―Feb―08 Stevens-Johnson Syndrome induced by Vaxvetria (AZD1222) Covid-19 vaccine C. Aimo, E.B. Mariotti, A. Corrà, E. Cipollini, O. Le Rose, C. Serravalle, et al. (+2)
147 [GO] 2022―Jan―29 The impact of the COVID-19 pandemic on keratinocyte carcinoma in the Netherlands: trends in diagnoses and magnitude of diagnostic delays E. Slotman, K. Schreuder, T.E.C. Nijsten, M. Wakkee, L. Hollestein, A. Mooyaart, et al. (+2)
148 [GO] 2022―Jan―26 Estimating the incidence of Covid-19 skin manifestations on the general population in a territorial setting Corrado Zengarini, Alba Guglielmo, Matteo Giovani, Cecilia Preci, Emi Dika, Bianca Maria Piraccini, Alessandro Pileri
149 [GO] 2022―Jan―25 Psoriasis flare-up after AZD1222 and BNT162b2 COVID-19 mRNA vaccines: report of twelve cases from a single centre Dimitra Koumaki, Sabine-Elke Krueger-Krasagakis, Marios Papadakis, Alexander C. Katoulis, Ioanna Gkiaouraki, Kyriaki Zografaki, et al. (+2)
150 [GO] 2022―Jan―24 Eruptive pyogenic granulomas following COVID-19. Carlo Alberto Maronese, Chiara Moltrasio, Dario Antonio Marletta, Giovanni Genovese, Angelo Valerio Marzano
151 [GO] 2022―Jan―24 Atopic Dermatitis exacerbation after Covid-19 vaccination in Dupilumab treated patients L. Potestio, M. Napolitano, L. Bennardo, G. Fabbrocini, C. Patruno
152 [GO] 2022―Jan―24 A study of COVID-19 vaccine (Covishield) induced dermatological adverse effects from India S Arora, G K Singh, P Das, R Rahman, P Bellad, R Shrivastav, et al. (+3)
153 [GO] 2022―Jan―24 Reply to “The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?” by Damiani G et al. G Avallone, S Giordano, C Astrua, M Merli, R Senetta, C Conforti, et al. (+3)
154 [GO] 2022―Jan―24 Incident bullous pemphigoid in a psoriatic patient following mRNA-1273 SARS-CoV-2 vaccination W.-K. Hung, C.-C. Chi
155 [GO] 2022―Jan―23 Cutaneous arteritis following mRNA-1273 Moderna COVID-19 vaccination T. Ogawa, U. Aitake, T. Nomura
156 [GO] 2022―Jan―23 A first case of “Covid toes” from a viral vector-based COVID-19 vaccine A. Van Loon, D. Mortelmans, V. Siozopoulou, B. Ogunjimi, H. Jansens, J. Lambert, O. Aerts
157 [GO] 2022―Jan―16 Skin adverse reactions to Sars-CoV-2 vaccination: a relevant responsibility issue for dermatologists P. Gisondi, F. Bellinato, G. Girolomoni
158 [GO] 2022―Jan―12 Eosinophilic panniculitis: a new side effect of Sinopharm COVID-19 vaccine Jerome Kaikati, Antoine Ghanem, Reem El Bahtimi, Josiane Helou, Roland Tomb
159 [GO] 2022―Jan―11 Clinical improvement of atopic dermatitis in two patients co-affected with non-severe COVID-19 infection: A case series and review of literature Gaetano Licata, Dario Buononato, Carmine Fiorentino, Giulia Calabrese, Alina De Rosa, Giuseppe Argenziano, Alessio Gambardella
160 [GO] 2022―Jan―11 Pityriasis lichenoides et varioliformis acuta following COVID-19 mRNA vaccination J Palmén, M Lepistö, L Talve, N Hieta
161 [GO] 2022―Jan―11 Wells’ syndrome following Oxford-AstraZeneca COVID-19 vaccination Yulhee Kim, You Chan Kim
162 [GO] 2022―Jan―11 Trigger of Type 2 Lepra reaction with acute foot drop following Covid-19 vaccination Anil Kumar Panda, Farheen Begum, Maitreyee Panda, Ajaya Kumar Jena
163 [GO] 2021―Dec―22 Extensive cutaneous lichen planus triggered by viral vector COVID-19 vaccination (ChAdOx1 nCoV-19) Clémence Masseran, Andreea Cӑlugӑreanu, Frédéric Caux, Gérôme Bohelay
164 [GO] 2021―Dec―21 Telemedicine and Dermatology Hospital Consultations During The COVID-19 Pandemic: A Multi-Center Observational Study on Resource Utilization and Conversion to In-Person Consultations During the COVID-19 Pandemic John Trinidad, Colleen K Gabel, Lauren Bonomo, Alexander Cartron, Sidharth Chand, William Coburn, et al. (+40)
165 [GO] 2021―Dec―20 Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: a report and brief literature review Michele Pauluzzi, Giuseppe Stinco, Enzo Errichetti
166 [GO] 2021―Dec―20 SCLE manifestation after mRNA COVID-19 vaccination Laura Rechtien, Cornelia Erfurt-Berge, Michael Sticherling
167 [GO] 2021―Dec―20 Cutaneous manifestations following COVID-19 vaccination: a multicentric descriptive cohort E. Massip, P. Marcant, G. Font, S. Faiz, S. Duvert-Lehembre, I. Alcaraz, et al. (+7)
168 [GO] 2021―Dec―20 High frequency of eosinophilia and viral reactivation in drug hypersensitivity in patients with SARS-CoV-2 infection. Baptiste Mille, Saskia Ingen-Housz-Oro, Nicolas De Prost, Guillaume Voiriot, Angèle Soria, Florence Tetart, et al. (+4)
169 [GO] 2021―Dec―20 Primitive melanoma and COVID 19 are we still paying the price of the pandemic? F. Ricci, G. Di Lella, L. Fania, F. Ricci, L. Sobrino, S. Pallotta, et al. (+3)
170 [GO] 2021―Dec―16 Exuberant lichenoid eruption after Oxford-AstraZeneca COVID-19 vaccine: a singular case C. Correia, S. Fernandes, L. Soares-de-Almeida, P. Filipe
171 [GO] 2021―Dec―12 Koebner phenomenon with lichen planus in an area of previous vitiligo after COVID-19 vaccination and the creation of a locus minoris resistentiae Alin Laurentiu Tatu, Thomas Nadasdy, LC Nwabudike
172 [GO] 2021―Dec―12 Reply to “New-onset cutaneous lichen planus triggered by COVID-19 vaccination” by Merhy et al. E Camela, G Guerrasio, C Patruno, M Scalvenzi, N Di Caprio, G Fabbrocini, M Napolitano
173 [GO] 2021―Dec―12 Development of pemphigus vulgaris following mRNA SARS-CoV-19 BNT162b2 vaccination in an 89-year-old patient G Knechtl, SM Seyed Jafari, T Berger, A Rammlmai, L Feldmeye, L Borradori
174 [GO] 2021―Dec―04 Trend of sexually transmitted infections during the Covid-19 age. Which was the impact of the pandemic and the social distancing measures? L. Ronga, S. Stolfa, F. Romanelli, D.F. Bavaro, A. Saracino, A. Mosca, et al. (+6)
175 [GO] 2021―Dec―04 Concomitant SARS-CoV-2 infection and crusted scabies in a 4-month infant A. Giannattasio, M. Rosa, S. Esposito, O. Di Mita, F. Angrisani, S. Acierno, et al. (+4)
176 [GO] 2021―Nov―28 Genital necrosis with cutaneous thrombosis after COVID-19 mRNA vaccination Ai Kuzumi, Ayumi Yoshizaki, Kazue Chiba, Shunki Mitsuo, Kazuki M Matsuda, Yuta Norimatsu, et al. (+4)
177 [GO] 2021―Nov―28 Pityrosporum folliculitis in critically ill COVID-19 patients Fernanda Lagares Xavier Peres, Renan Rangel Bonamigo, Gustavo Borchardt Bottega, Fernanda Luiza Staub, André da Silva Cartell, Bakos Marchiori Renato
178 [GO] 2021―Nov―28 Multisystem inflammatory syndrome in adults (MIS-A): a new addition to Covid-19 puzzle Kaushiki Hajra, Uddalak Chakraborty, Kingshuk Chatterjee, Atanu Chandra, Saswati Halder
179 [GO] 2021―Nov―22 COVID-19 cutaneous manifestations in pediatric patients: 24 MIS-C and 6 Kawasaki disease cases A. Tammaro, D. Karim, G. A. R. Adebanjo, F. R. Parisella, C. Chello, A. F. Salih, J. Rello
180 [GO] 2021―Nov―22 Lack of association between seborrheic dermatitis and SARS-CoV-2 outcomes Uros Rakita, Trisha Kaundinya, Armaan Guraya, Kamaria Nelson, Brittany Maner, Jaya Manjunath, et al. (+3)
181 [GO] 2021―Nov―22 Subacute cutaneous lupus erythematosus induction after SARS-CoV-2 Vaccine in a patient with primary biliary cholangitis Corrado Zengarini, Alessandro Pileri, Francesco Paolo Salamone, Bianca Maria Piraccini, Giovanni Vitale, Michelangelo La Placa
182 [GO] 2021―Nov―13 Another year in the grip of COVID-19 with slow recovery J. Ring
183 [GO] 2021―Nov―10 Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity R. Molinier, A. Roger, B. Genet, A. Blom, C. Longvert, L. Chaplain, et al. (+3)
184 [GO] 2021―Nov―10 Eosinophilic dermatosis after AstraZeneca COVID-19 vaccination Elisa Cinotti, Jean-Luc Perrot, Francesco Bruzziches, Linda Tognetti, Anastasia Batsikosta, Ester Sorrentino, et al. (+2)
185 [GO] 2021―Nov―10 Non-invasive instrumental examinations of cutaneous, adnexal and mucosal manifestations after SARS-COV-2 infection in adult and children I. Proietti, E. Tolino, A. Mambrin, N. Skroza, N. Bernardini, A. Marchesiello, et al. (+7)
186 [GO] 2021―Nov―10 Dermatologic emergency unit, day-care hospital and consultations in time of COVID-19: the impact of teledermatology Alice Brehon, Jason Shourick, Camille Hua, Charbel Skayem, Pierre Wolkenstein, Olivier Chosidow, Tu Anh Duong
187 [GO] 2021―Nov―09 At-risk circumstances for COVID-19 increase the risk of pruritus: cross-sectional and longitudinal analyses T. Kogame, Y. Ogawa, K. Kabashima, Y. Yamamoto
188 [GO] 2021―Nov―09 Lymphomatoid drug reaction developed after BNT162b2 (Comirnaty) COVID-19 vaccine manifesting as pityriasis lichenoides et varioliformis acuta-like eruption A. Sernicola, A. Dybala, V. Gomes, P. Maddalena, F. Adotti, G. Soda, et al. (+4)
189 [GO] 2021―Oct―26 Regression of common viral warts after ChAdOx1-S COVID-19 vaccine Anna Płaszczyńska, Martyna Sławińska, Michał Sobjanek
190 [GO] 2021―Oct―20 Erythema nodosum following the first dose of ChAdOx1-S nCoV-19 vaccine N. Cameli, M. Silvestri, M. Mariano, L. Bennardo, S.P. Nisticò, A. Cristaudo
191 [GO] 2021―Oct―19 Incidence and Prognosis of COVID-19 in Patients with Psoriasis on Apremilast: A Multicenter Retrospective Cohort Study Yuliya Lytvyn, Jorge R Georgakopoulos, Asfandyar Mufti, Alim R. Devani, Melinda J. Gooderham, Vipul Jain, et al. (+4)
192 [GO] 2021―Oct―19 Comment on “Development of eruptive pseudoangiomatosis following COVID-19 inmunization-apropos of 5 cases”: could eruptive pseudoangiomatosis represent a paraviral eruption associated with SARS-CoV-2? Cristina Moya-Martinez, Emilio de Dios Berná-Rico, Ana Melian-Olivera, Carmen Moreno-Garcia del Real, Diego Fernández-Nieto
193 [GO] 2021―Oct―19 Cutaneous adverse reactions from 35,229 doses of Sinovac and AstraZeneca COVID-19 vaccination: A prospective cohort study in healthcare workers Pawinee Rerknimitr, Thanaporn Puaratanaarunkon, Chanidapa Wongtada, Namthong Wittayabusarakam, Saran Krithin, Leilani Paitoonpong, et al. (+5)
194 [GO] 2021―Oct―19 Response to ‘A skin reaction with rust-like discolouration to mRNA COVID-19 vaccine C Kouki, K Sellami, E Bahloul, M Amouri, A Masmoudi, H Turki
195 [GO] 2021―Oct―19 Generalized erythema multiforme-like skin rash following the first dose of COVID-19 vaccine (Pfizer-BioNTech) Minjae Kim, Jee Woo Kim, Minsu Kim, Sun Young Choi, Jung-Im Na
196 [GO] 2021―Oct―19 Severe necrotizing myopathy after COVID-19 vaccine with BNT162b2 and regimen with ipilimumab plus nivolumab in a patient with advanced melanoma Manon Blaise, Fanny Rocher, Hélène Spittler, Adrien Sanchez, Elisabeth Lanteri, Lucia Coco, et al. (+5)
197 [GO] 2021―Oct―19 Cutaneous findings following COVID-19 vaccination: review of world literature and own experience T. Gambichler, S. Boms, L. Susok, H. Dickel, C. Finis, N. Abu Rached, et al. (+3)
198 [GO] 2021―Oct―10 Recurrence of Cutaneous T-cell lymphoma (CTCL) post viral vector COVID-19 vaccination E Panou, V Nikolaou, L Marinos, S Kallambou, P Sidiropoulou, M Gerochristou, A Stratigos
199 [GO] 2021―Oct―05 Herpes Zoster Viral (HZV) infection after AZD1222 and BNT162b2 COVID-19 mRNA vaccines: a case series. Dimitra Koumaki, Sabine-Elke Krueger-Krasagakis, Marios Papadakis, Alexander Katoulis, Vasiliki Koumaki, George Evangelou, et al. (+4)
200 [GO] 2021―Oct―05 SARS-CoV-2 Serology In Patients On Biological Therapy or Apremilast For Psoriasis: A Study of 93 Patients in the Italian Red Zone Syed M. A. Ahmed, Martina Volontè, Eugenio Isoletta, Camilla Vassallo, Carlo Francesco Tomasini, Daniele Lilleri, et al. (+4)
201 [GO] 2021―Oct―05 Eruptive angiomatosis after SARS-CoV-2 Vaccine (Comirnaty, Pfizer) Corrado Zengarini, Cosimo Misciali, Tiziana Lazzarotto, Emi Dika
202 [GO] 2021―Sep―21 Are the chilblain-like lesions observed during the COVID-19 pandemic due to SARS-CoV-2? Systematic review and meta-analysis V. Sánchez-García, R. Hernández-Quiles, E. de-Miguel-Balsa, A. Docampo-Simón, I. Belinchón-Romero, J.M. Ramos-Rincón
203 [GO] 2021―Sep―21 Personal protective equipment use and face acne in health care providers during the COVID-19 pandemic in Romania: a new occupational acne type? S Cretu, M Dascalu, SR Georgescu, CM Salavastru
204 [GO] 2021―Sep―21 Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccine Laurence Montjoye, Liliane Marot, Marie Baeck
205 [GO] 2021―Sep―21 Early atypical injection-site reactions to COVID-19 vaccine: a case series M. Vaccaro, L. Bertino, R. Squeri, C. Genovese, S. Isola, G. Spatari, et al. (+2)
206 [GO] 2021―Sep―21 Erythema nodosum, zoster duplex and pityriasis rosea as possible cutaneous adverse effects of Oxford-AstraZeneca COVID-19 vaccine: report of three cases from India Hitaishi Mehta, Sanjeev Handa, Pankaj Malhotra, Meenakshi Patial, Smriti Gupta, Anirudh Mukherjee, et al. (+3)
207 [GO] 2021―Sep―21 New-onset and exacerbations of psoriasis after mRNA COVID-19 vaccines: two sides of the same coin? David Pesqué, Emilio Lopez-Trujillo, Orianna Marcantonio, Ana Maria Giménez-Arnau, Ramon Maria Pujol
208 [GO] 2021―Sep―21 A case of bullous pemphigoid after the SARS-CoV-2 mRNA vaccine J. Young, L. Mercieca, M. Ceci, D. Pisani, A. Betts, M.J. Boffa
209 [GO] 2021―Sep―21 SARS-CoV-2 mRNA Vaccine Injection Site Pseudolymphoma Dillon Mintoff, Lawrence Scerri, Alexandra Betts
210 [GO] 2021―Sep―21 Pfizer-BioNTech SARS-CoV-2 mRNA Vaccine-associated Erythema Multiforme Luca Borg, Liam Mercieca, Dillon Mintoff, Daniel Micallef, David Pisani, Alexandra Betts, Lawrence Scerri
211 [GO] 2021―Sep―21 Erythema multiforme after SARS-CoV-2 vaccine Li-wen Zhang, Wen-ju Wang, Cong-hui Li, Tao Chen
212 [GO] 2021―Sep―21 Nevocentric erythema multiforme after SARS-COV-2 Vaccine C. Scharf, E. V. Brizzi, S. Pellerone, M. Liguori, C.M.R. Giorgio, G. Argenziano
213 [GO] 2021―Sep―17 Reply to “Psoriasis exacerbation after Covid-19 vaccination: report of 14 cases from a single center” by Sotiriou E et al. M. Megna, L. Potestio, L. Gallo, G. Caiazzo, A. Ruggiero, G. Fabbrocini
214 [GO] 2021―Sep―07 Two cases of pityriasis rosea after the injection of coronavirus disease 2019 vaccine Linting Huang, Zhirong Yao, Jia Zhang
215 [GO] 2021―Sep―06 COVID-19 and skin diseases: results from a survey of 843 patients with atopic dermatitis, psoriasis, vitiligo, and chronic urticaria P.R. Criado, M. Ianhez, C.C. Silva de Castro, C. Talhari, P.M. Ramos, H.A. Miot
216 [GO] 2021―Sep―06 Changes in the incidence of contagious infectious skin diseases after the COVID-19 outbreak EJ Chun, JK Kim, SY Yang, SS Kim, CW Kim
217 [GO] 2021―Sep―06 Erythema annulare centrifugum triggered by SARS-CoV-2 infection N Setó-Torrent, A Altemir, M Iglesias-Sancho, MT Fernández-Figueras
218 [GO] 2021―Aug―30 Clinicopathological features of cutaneous reactions after mRNA-based COVID-19 vaccines M. Tihy, S. Menzinger, R. André, E. Laffitte, L. Toutous-Trellu, G. Kaya
219 [GO] 2021―Aug―21 The crucial role of clinicopathological correlation in COVID-19-related cutaneous manifestations F. Rongioletti
220 [GO] 2021―Aug―20 SARS-CoV-2 in the sweat of COVID-19 positive patients: a possible route of transmission? S. Recalcati, S. Tonolo, E. Meroni, F. Fantini
221 [GO] 2021―Aug―20 Flagellate Purpura Associated With COVID-19 Vaccination Emma Heck, Brian D. Rankin, Michelle Schneider, Vimal H. Prajapati
222 [GO] 2021―Aug―20 Two cases of papulo-pustular rosacea-like eruptions following COVID-19 vaccinations G Ciccarese, F Drago, A Rebora, A Parodi
223 [GO] 2021―Aug―09 Cutaneous reactions following CoronaVac COVID-19 vaccination: a case series of six healthcare workers from a single center Elçin Akdaş, Betül Öğüt, Özlem Erdem, Murat Orhan Öztaş, Nilsel İlter
224 [GO] 2021―Aug―07 Erythema Gyratum Repens after COVID-19 R Castro Silva, G Castro Silva, MC Castro Silva, O Lupi
225 [GO] 2021―Aug―07 Characteristics of facial skin problems and microbiome variation during wearing masks for fighting against COVID-19 Chenyang Huang, Qingmiao Sun, Daixi Jiang, Xiaobao Zhang, Can Chen, Danying Yan, et al. (+9)
226 [GO] 2021―Aug―07 Psoriasis exacerbation after Covid-19 vaccination: report of 14 cases from a single center E Sotiriou, A Tsentemeidou, K Bakirtzi, A Lallas, D Ioannides, E Vakirlis
227 [GO] 2021―Aug―07 Three cases of vesiculobullous non-IgE-mediated cutaneous reactions to tozinameran (Pfizer-BioNTech COVID-19 vaccine) Lester Juay, Nisha Suyien Chandran
228 [GO] 2021―Aug―07 Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literature E. Annabi, N. Dupin, P. Sohier, B. Garel, N. Franck, S. Aractingi, et al. (+2)
229 [GO] 2021―Aug―07 Cutaneous reactions to inactivated SARS-CoV-2 vaccine and ChAdOx1-S (recombinant) vaccine against SARS-CoV-2: A case series from the Philippines J.N. Yu, C.B. Angeles, H.G. Lim, C. Chavez, C. Roxas-Rosete
230 [GO] 2021―Aug―07 Herpes zoster after inactivated SARS-CoV-2 vaccine in two healthy young adults Ahmet Kağan Özdemir, Sera Kayhan, Seray Külcü Çakmak
231 [GO] 2021―Aug―07 Herpes zoster after ChAdOx1 nCoV-19 vaccine: a case series Maria Vastarella, Vincenzo Picone, Fabrizio Martora, Gabriella Fabbrocini
232 [GO] 2021―Jul―26 Cutaneous manifestations of patients hospitalized with coronavirus disease 2019 (COVID-19) P Ramezani Darmian, Z Memarzadeh, R Aryan, Y Nahidi, Z Mehri, A taghipour, et al. (+3)
233 [GO] 2021―Jul―26 Dermatoses caused by face mask wearing during the COVID-19 pandemic Olga Yu. Olisova, Natalia P. Teplyuk, Ekaterina V. Grekova, Anfisa A. Lepekhova
234 [GO] 2021―Jul―26 The impact of the COVID-19 pandemic on diagnostic delay of skin cancer: a call to restart screening activities Clio Dessinioti, Claus Garbe, Alexander J Stratigos
235 [GO] 2021―Jul―26 New onset of mainly guttate psoriasis after COVID-19 vaccination: a case report M. Lehmann, P. Schorno, R. E. Hunger, K. Heidemeyer, L. Feldmeyer
236 [GO] 2021―Jul―26 Omalizumab prevents anaphylactoid reactions to mRNA COVID-19 vaccine A. Smola, S. Samazadeh, L. Müller, O. Adams, B. Homey, P. Albrecht, S. Meller
237 [GO] 2021―Jul―26 A skin reaction with rust-like discolouration to mRNA COVID-19 vaccine R. Pasternack, S. Pohjavaara
238 [GO] 2021―Jul―26 Small vessel vasculitis related to varicella zoster virus after Pfizer-BioNTech COVID-19 vaccine Francesca Nastro, Gabriella Fabbrocini, Francesca di Vico, Claudio Marasca
239 [GO] 2021―Jul―26 Pityriasis rubra pilaris after Vaxzevria® COVID-19 vaccine Iñigo Lladó, Beatriz Butrón-Bris, Raquel Sampedro-Ruiz, Javier Fraga, Diego de Argila
240 [GO] 2021―Jul―26 Small vessel vasculitis following Oxford-AstraZeneca vaccination against SARS-CoV-2 Luisa Guzmán-Pérez, Mario Puerta-Peña, Daniel Falkenhain-López, Julia Montero-Menárguez, Christian Gutiérrez-Collar, José Luis Rodríguez-Peralto, Jimena Sanz-Bueno
241 [GO] 2021―Jul―26 Retiform purpura and extensive skin necrosis as the single manifestation of SARS-CoV-2 infection M. Brito Caldeira, M. Pestana, A. Luísa João, C. Fernandes, A. João, N. Cunha
242 [GO] 2021―Jul―26 Herpes Zoster following SARS-CoV-2 vaccination - a series of 4 cases M Alpalhão, P Filipe
243 [GO] 2021―Jul―26 New-onset acral lesions on hands after administration of mRNA-1273 vaccine against SARS-CoV-2: Clinical images and histopathological study of 3 cases D. Revilla-Nebreda, M. Roncero-Riesco, Á. Santos-Briz, M. Medina-Migueláñez, N. Segurado-Tostón, C. Román-Curto
244 [GO] 2021―Jul―23 Prevalence and characteristics of dermatological manifestations in COVID-19 positive dermatologists: Report from a web-based survey in India Deepak Jakhar, Anupam Das, Subuhi Kaul, Ishmeet Kaur, Bhushan Madke, Ashish Dalal
245 [GO] 2021―Jul―14 Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-center cohort study Erica Koch, Francisco Villanueva, Michael A. Marchetti, Álvaro Abarzúa, Consuelo Cárdenas, Juan Camilo Castro, et al. (+13)
246 [GO] 2021―Jul―09 Transition of cutaneous into systemic lupus erythematosus following adenoviral vector based SARS-CoV-2 vaccination Alexander Kreuter, Sven-Niklas Burmann, Björn Burckert, Frank Oellig, Alena-Lioba Michalowitz
247 [GO] 2021―Jul―09 “COVID arm” - histological features of a delayed type hypersensitivity reaction to Moderna mRNA-1273 SARS-CoV2 vaccine W. Kempf, N. Kettelhack, F. Kind, S. Courvoisier, J. Galambos, K. Pfaltz
248 [GO] 2021―Jul―08 Development of eruptive pseudoangiomatosis following COVID-19 immunization- apropos of 5 cases Alpana Mohta, Suresh Kumar Jain, Rajesh Dutt Mehta, Aakanksha Arora
249 [GO] 2021―Jul―08 Pityriasis rosea developing after COVID-19 vaccination O. Marcantonio-Santa Cruz, A. Vidal-Navarro, D. Pesqué, A.M. Giménez-Arnau, R.M. Pujol, G. Martin-Ezquerra
250 [GO] 2021―Jul―08 New-onset cutaneous lichen planus triggered by COVID-19 vaccination R. Merhy, A.S Sarkis, J. Kaikati, L. El Khoury, S. Ghosn, F. Stephan
251 [GO] 2021―Jul―08 Generalized eczematous reactions to the Pfizer-BioNTech COVID-19 vaccine AC Leasure, S Cowper, J McNiff, JM Cohen
252 [GO] 2021―Jul―08 Pernio-like skin lesions after the second dose of Pfizer-BioNTech COVID-19 vaccine N. Cameli, M. Silvestri, M. Mariano, S.P. Nisticò, A. Cristaudo
253 [GO] 2021―Jul―08 New onset of Remitting Seronegative Symmetrical Synovitis with Pitting Oedema and Palmoplantar Psoriasis flare-up after Sars-Cov-2 Vaccination L Quattrini, L Verardi, G Caldarola, G Peluso, C De Simone, M D’Agostino
254 [GO] 2021―Jul―08 Widespread purpura annularis telangiectodes following mRNA SARS-CoV-2 vaccine. D Falkenhain-López, C Gutiérrez-Collar, J Arroyo-Andrés, I Gallego-Gutiérrez, JL Rodríguez-Peralto, A Sánchez-Velázquez
255 [GO] 2021―Jun―25 The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated? Giovanni Damiani, Alessia Pacifico, Francesco Pelloni, Matilde Iorizzo
256 [GO] 2021―Jun―25 Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2 Farzan Solimani, Yasmine Mansour, Dario Didona, Amrei Dilling, Kamran Ghoreschi, Katharina Meier
257 [GO] 2021―Jun―24 Delayed cutaneous reaction to ChAdOx1 nCoV-19 vaccine: Is it an ‘AstraZeneca arm’? Jeong Eun Kim, Hyun Lee, Seung Sam Paik, Ji-Yong Moon, Ho Joo Yoon, Sang-Heon Kim
258 [GO] 2021―Jun―19 Evolution of notified sexually transmitted infections in Barcelona during the First Wave of the COVID-19 Pandemic Gemma Martin-Ezquerra, Pablo Monreal, Lilas Mercuriali, Esperanza Cañas-Ruano, Ramon M Pujol, Xavier Duran, et al. (+28)
259 [GO] 2021―Jun―19 The Significance of Exanthems in COVID-19 Patients Hospitalized at a Tertiary Care Center Renajd Rrapi, Sidharth Chand, Jennifer A. Lo, Colleen K Gabel, Sarah Song, Zachary Holcomb, et al. (+9)
260 [GO] 2021―Jun―18 Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study SK Mahil, M Yates, ZZN Yiu, SM Langan, T Tsakok, N Dand, et al. (+31)
261 [GO] 2021―Jun―16 Psoriasis flare up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine PK Krajewski, Ł Matusiak, JC Szepietowski
262 [GO] 2021―Jun―16 Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that ‘COVID toes’ are due to the immune reaction to SARS-CoV-2 C. Lesort, J. Kanitakis, L. Donzier, D. Jullien
263 [GO] 2021―Jun―16 A review of nail findings associated with COVID-19 infection Edward Hadeler, Brian W. Morrison, Antonella Tosti
264 [GO] 2021―Jun―16 Adverse Skin Reactions Due to Use of Face Masks: A Prospective Survey during the COVID-19 Pandemic in Korea S.J. Park, H.S. Han, S.H. Shin, K.H. Yoo, K. Li, B.J. Kim, et al. (+2)
265 [GO] 2021―Jun―03 Contemporary occurrence of Chilblain-like lesions and Pityriasis rosea during the COVID-19 pandemic Vincenzo Piccolo, Andrea Bassi, Giuseppe Argenziano, Carlo Mazzatenta, Mario Cutrone, Iria Neri, et al. (+2)
266 [GO] 2021―Jun―02 Patients with Primary Cutaneous Lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry A. Sánchez-Velázquez, A. Bauer-Alonso, T. Estrach, D. Vega-Díez, P. Garcia-Muret, L. Haya, et al. (+26)
267 [GO] 2021―Jun―02 Immune thrombocytopenic purpura associated with COVID-19 Pfizer-BioNTech BNT16B2b2 mRNA vaccine PK Krajewski, JC Szepietowski
268 [GO] 2021―May―31 Ipsilateral Herpes Zoster after the first dose of BNT162b2 mRNA COVID-19 vaccine Ioannis Tessas, Nicolas Kluger
269 [GO] 2021―May―31 Acute postinfectious Pityriasis Rubra Pilaris as a cutaneous manifestation in COVID-19: a case report and its dermoscopic features. D. Kadylak, W. Barańska-Rybak
270 [GO] 2021―May―28 Purpuric lesions on the eyelids developed after BNT162b2 mRNA COVID-19 vaccine: another piece of SARS-CoV-2 skin puzzle? C. Mazzatenta, V. Piccolo, G. Pace, I. Romano, G. Argenziano, A. Bassi
271 [GO] 2021―May―26 Frequency of relapse and persistent cutaneous symptoms after a first episode of chilblain-like lesion during the COVID-19 pandemic Parna Moghadam, Laure Frumholtz, Léa Jaume, Adèle De Masson, Marie Jachiet, Edouard Begon, et al. (+6)
272 [GO] 2021―May―26 Dapsone induced methemoglobinemia in leprosy: A close mimic of ‘happy hypoxia’ in the COVID-19 pandemic Tanu Tripathi, Anchit Raj Singh, Rajan Kapoor, Anwita Sinha, Saikat Ghosh, Kanwaljit Kaur, et al. (+4)
273 [GO] 2021―May―26 SARS-CoV-2 mRNA Vaccine-Associated Fixed Drug Eruption Dillon Mintoff, David Pisani, Alexandra Betts, Lawrence Scerri
274 [GO] 2021―May―25 Urticarial Vasculitis revealing immunolabelled nucleocapsid protein of SARS-CoV-2 in two Brazilian asymptomatic patients: the tip of the COVID-19 hidden iceberg? Paulo Ricardo Criado, Roberta Fachini Jardim Criado, Raffaele Gianotti, Beatrice Artinez Zugaib Abdalla, Thais Prota Hussein Pincelli, Alexandre Osores Michalany, Nilceo Schwery Michalany
275 [GO] 2021―May―22 Cutaneous adverse reactions after m-RNA COVID-19 vaccine: early reports from North-East Italy E. Farinazzo, G. Ponis, E. Zelin, E. Errichetti, G. Stinco, C. Pinzani, et al. (+9)
276 [GO] 2021―May―20 Detection of a second outbreak of chilblain-like lesions during COVID-19 pandemic through teledermatology Laura Giraud-Kerleroux, Margaux Mongereau, Charles Cassius, Marc Mrad, Charlotte Gary, Caroline Fiani, et al. (+9)
277 [GO] 2021―May―20 Not all that glitters is COVID-19: a case-series demonstrating the need for histopathology when skin findings accompany SARS-CoV-2 infection A Barrera-Godínez, S Méndez-Flores, M Gatica-Torres, A Rosales-Sotomayor, KI Campos-Jiménez, DM Carrillo-Córdova, et al. (+8)
278 [GO] 2021―May―20 SARS-CoV-2: skin diseases, mask wearing and unpleasant sensations B Cribier, C Taieb, M Saint Aroman, J Shourick
279 [GO] 2021―May―14 Heterogeneous red-white discoloration of the nail bed and distal onycholysis in a patient with COVID-19 Betul Demir, Esma Inan Yuksel, Demet Cicek, Sedatcan Turkoglu
280 [GO] 2021―May―13 Androgenetic alopecia in women and men is not related to COVID-19 infection severity: A prospective cohort study of hospitalized COVID-19 patients Shatila Torabi, Mahnaz Mozdourian, Roxana Rezazadeh, Abolfazl Payandeh, Shapour Badiee, Emadodin Darchini-Maragheh
281 [GO] 2021―May―13 Recurrent injection-site reactions after incorrect subcutaneous administration of a COVID-19 vaccine M Gyldenløve, L Skov, CB Hansen, P Garred
282 [GO] 2021―May―13 Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine Benoit Cyrenne, Faisal Al-Mohammedi, Joel DeKoven, Raed Alhusayen
283 [GO] 2021―Apr―29 Adamantiades-Behçet’s disease (Behçet’s disease) and COVID-19 C.C. Zouboulis, J.A.M. Laar, M. Schirmer, G. Emmi, F. Fortune, A. Gül, et al. (+5)
284 [GO] 2021―Apr―29 Non-acral skin manifestations during the COVID-19 epidemic: COVIDSKIN study by the French Society of Dermatology R Guelimi, R Salle, L Dousset, H Assier, S Fourati, Z Bhujoo, et al. (+18)
285 [GO] 2021―Apr―29 Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report Elçin Akdaş, Nilsel İlter, Betül Öğüt, Özlem Erdem
286 [GO] 2021―Apr―29 BNT162b2 mRNA Covid-19 Vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2 Vincenzo Piccolo, Andrea Bassi, Giuseppe Argenziano, Carlo Mazzatenta, Mario Cutrone, Iria Neri, et al. (+2)
287 [GO] 2021―Apr―26 “Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance” JM Busto-Leis, G Servera-Negre, A Mayor-Ibarguren, E Sendagorta-Cudós, M Feito-Rodríguez, A Nuño-González, et al. (+2)
288 [GO] 2021―Apr―20 Incidence and prognosis of COVID-19 in psoriasis patients on biologic therapy: a multicenter retrospective cohort study Jorge R. Georgakopoulos, Asfandyar Mufti, Ron Vender, Vimal H. Prajapati, Jensen Yeung
289 [GO] 2021―Apr―19 Covid-19-triggered sarcoidal granulomas mimicking scar sarcoidosis A Polat Ekinci, N Büyükbabani, S Meşe, G Pehlivan, NG Okumuş, A Ağaçfidan, E Özkaya
290 [GO] 2021―Apr―19 Recurrence of previous chilblain lesions during the second wave of COVID-19: can we still doubt the correlation with SARS-CoV-2? S Signa, AR Sementa, MC Coccia, C Pastorino, G Viglizzo, S Viola, et al. (+7)
291 [GO] 2021―Apr―18 Adverse skin reactions related to PPE among health care workers managing COVID-19 Priyanka Sharma, Nainika Goel, Kanika Dogar, Mala Bhalla, GP Thami, Kavita Punia
292 [GO] 2021―Apr―18 Under-representation of people of African ancestry in publications on the cutaneous manifestations of COVID-19: coincidence or physiology? C Cassius, L Frumholtz, A de Masson, O Dadzie, A Petit
293 [GO] 2021―Apr―18 Penile ischemia secondary to COVID-19: Why should the dermatologist be concerned? P. Sarkis, J. Sarkis, M. Alkassis, J. Assaf, K. El Gharib
294 [GO] 2021―Apr―09 Good tolerance of hyaluronic acid injections during the period of the Covid-19 pandemic: observing a cohort of 1093 patients in a prospective, observational real-life study Michael Naouri, Serge Dahan, Anne Le Pillouer Prost, Phrynée Coutant-Foulc, Catherine Raimbault, Françoise Cucurella, et al. (+10)
295 [GO] 2021―Apr―09 Transient cutaneous manifestations after administration of Pfizer-BioNTech COVID-19 Vaccine: an Italian single centre case series M. Corbeddu, A. Diociaiuti, MR. Vinci, A. Santoro, V. Camisa, S. Zaffina, M. El Hachem
296 [GO] 2021―Apr―08 Nail changes as manifestation of systemic disease in COVID-19 infection SS Ocampo-Garza, J Ocampo-Candiani, E Camela, M Vastarella, G Fabbrocini, M Scalvenzi, A Villani
297 [GO] 2021―Mar―30 Extraordinary Claims Without Extraordinary Evidence Controversy on Anti-Androgen Therapy for COVID-19 R.M. Trüeb, A. Régnier, N. Caballero-Uribe, M.F. Reis Gavazzoni Dias, H. Dutra Rezende
298 [GO] 2021―Mar―30 Persistent maculopapular rash after the first dose of Pfizer-BioNTech COVID-19 vaccine. M Ackerman, D Henry, A Finon, R Binois, E Esteve
299 [GO] 2021―Mar―30 Skin manifestations of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers. “COVID-arm”: a clinical and histological characterization D. Fernandez-Nieto, J. Hammerle, M. Fernandez-Escribano, CM Moreno-del Real, P. Garcia-Abellas, I. Carretero-Barrio, et al. (+5)
300 [GO] 2021―Mar―29 Position statement of the EADV Melanoma Task Force on recommendations for the management of cutaneous melanoma patients during COVID-19 M. Arenbergerova, A. Lallas, E. Nagore, L. Rudnicka, A. Forsea, M. Pasek, et al. (+4)
301 [GO] 2021―Mar―29 A new virtual inpatient dermatology electronic referral service: a timely solution in the COVID-19 pandemic and beyond? A Lowe, A Pararajasingam, FM Ali, S Dawood, CD Lowe, NM Stone
302 [GO] 2021―Mar―29 VACCINATION AGAINST SARS-COV-2 and PSORIASIS: the three things every dermatologist should know F. Diotallevi, A. Campanati, G. Radi, E. Martina, G. Rizzetto, P Barbadoro, et al. (+2)
303 [GO] 2021―Mar―22 Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts J Ring, M Worm, A Wollenberg, JP Thyssen, T Jakob, L Klimek, et al. (+30)
304 [GO] 2021―Mar―17 Follow-up of dermatological manifestations in non-critical hospitalized patients with COVID-19 pneumonia and their prognostic correlation with disease severity A García-Irigoyen, GA Acatitla-Acevedo, A Barrera-Godínez, S Méndez-Flores, J Domínguez-Cherit
305 [GO] 2021―Mar―16 COVID-19 pandemic and autoimmune bullous diseases: A cross-sectional study of the International Pemphigus and Pemphigoid Foundation M. Kasperkiewicz, M. Yale, R. Strong, D. Zillikens, D.T. Woodley, A. Recke
306 [GO] 2021―Mar―16 Periocular capillaritis in a COVID-19 positive patient: report of a case A Paganelli, F Garbarino, L Bigi
307 [GO] 2021―Mar―16 Lichen planus arising after COVID-19 vaccination I. Hiltun, J. Sarriugarte, I. Martínez-de-Espronceda, A. Garcés, C. Llanos, R. Vives, J.I. Yanguas
308 [GO] 2021―Mar―16 Prompt onset of erythema multiforme following the first BNT162b2 SARS-CoV-2 vaccination T. Gambichler, L. Scholl, L. Ocker, R. Stranzenbach
309 [GO] 2021―Mar―03 Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic M. Kasperkiewicz, E. Schmidt, M. Amagai, J.A. Fairley, P. Joly, D.F. Murrell, et al. (+4)
310 [GO] 2021―Mar―02 Association Between COVID-19 and Chilblains: A Case-Control Study Daniel Ortega-Quijano, Diego Fernandez-Nieto, Juan Jimenez-Cauhe, Jose Luis Cortes-Cuevas, Daniel Marcos-Mencia, Mario Rodriguez-Dominguez, et al. (+3)
311 [GO] 2021―Mar―02 Insights into COVID-19 vaccination in patients with chronic plaque psoriasis on systemic treatments P Gisondi, D Geat, L Naldi, S Piaserico
312 [GO] 2021―Mar―02 Chilblains in a child with confirmed SARS-CoV-2 infection: a red flag for late onset skin manifestation in previously infected individuals Iria Neri, Francesca Conti, Annalucia Virdi, Alba Guglielmo, Lucia Leonardi, Ilaria Corsini, et al. (+6)
313 [GO] 2021―Feb―18 European Task Force on Atopic Dermatitis (ETFAD): position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics Jacob P. Thyssen, Christian Vestergaard, Sebastien Barbarot, Marjolein S. de Bruin-Weller, Thomas Bieber, Alain Taieb, et al. (+29)
314 [GO] 2021―Feb―15 Relapse of chilblain-like lesions during the second wave of COVID-19 S. Recalcati, T. Barbagallo, S. Tonolo, M. Milani, F. Fantini
315 [GO] 2021―Feb―15 COVID-19 and immune checkpoint inhibitors M.S. Ahmed, H. Brehme, S. Friedrich, L. Reinhardt, S. Blum, S. Beissert, F. Meier
316 [GO] 2021―Feb―15 An Irish Department of Genito-Urinary Medicine in the COVID-19 Era D. Moriarty, C O’Connor, J. Bourke, M Murphy, M. Horgan, S Cremin
317 [GO] 2021―Feb―15 Concerns and perceptions of patients with psoriatic disease during the COVID-19 pandemic: results from a two-wave survey by the National Psoriasis Foundation G.C. Gondo, S.J. Bell, J. Slayden, G. Ullmann, A. Blauvelt
318 [GO] 2021―Feb―15 Rapidly progressive alopecia areata totalis in a Covid-19 patient, unresponsive to tofacitinib S. Berbert Ferreira, M.F.R. Gavazzoni Dias, R. Berbert Ferreira, A.C. Neves Neto, R.M. Trüeb, O. Lupi
319 [GO] 2021―Feb―15 Is SARS-CoV-2 screening test indicated for psoriasis patients candidate to biologic therapy? S. Piaserico, P. Gisondi, S. Cazzaniga, G. Girolomoni, PG. Calzavara-Pinton, L. Naldi
320 [GO] 2021―Feb―06 Absence of SARS-CoV-2 RNA detection in tissue samples of COVID-19-related cutaneous lesions analyzed by real-time RT-PCR MF García-Gil, J Monte-Serrano, M García García, Lucia Prieto-Torres, AJ Pascual-del-Riquelme, I Casas Flecha, M Ara-Martín
321 [GO] 2021―Feb―06 Chilblain-like lesions and COVID-19: second wave, second outbreak Vincenzo Piccolo, Andrea Bassi, Teresa Russo, Carlo Mazzatenta, Maura Baraldi, Giuseppe Argenziano, et al. (+2)
322 [GO] 2021―Feb―06 Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond J. Beecker, K.A. Papp, J. Dutz, R.B. Vender, R. Gniadecki, C. Cooper, et al. (+8)
323 [GO] 2021―Jan―18 COVID-19 and HHV8 first spotted together: an affair under electron microscopy E. Leoni, M. Cerati, G. Finzi, M. Lombardo, F. Sessa
324 [GO] 2021―Jan―15 Dermato-venereology in the year of coronavirus - Hot topics in research and patient care J. Ring
325 [GO] 2020―Dec―23 COVID-19 has changed our society as well as Dermatology J. Ring
326 [GO] 2020―Dec―23 Corrigendum: Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines E. Papadavid, J. Scaribrick, P. Ortiz Romero, P. Quaglino, M. Vermeer, R. Knobler, et al. (+2)
327 [GO] 2020―Dec―18 Understanding Views of Patients on Biologics for Psoriasis Amid the COVID-19 Pandemic Karan Pandher, Caroline L. Porter, Hiral S. Patel, William W. Huang, Steven R. Feldman
328 [GO] 2020―Dec―09 Palmoplantar erythrodysestesia: a diagnostic sign of COVID-19 Almudena Nuno-Gonzalez, Kyrylo Magaletsky, Marta Feito Rodríguez, Ander Mayor Ibarguren, Maria Jose Beato, Elena Ruiz Bravo, Pedro Herranz Pinto
329 [GO] 2020―Dec―01 Lack of skin manifestations in COVID-19 hospitalized patients during the second epidemic wave in Spain: a possible association with a novel SARS-CoV-2 variant. A cross-sectional study. D. Fernandez-Nieto, D. Ortega-Quijano, A. Suarez-Valle, J. Jimenez-Cauhe, P. Jaen-Olasolo, M. Fernandez-Guarino
330 [GO] 2020―Dec―01 Pityriasis rosea as a leading manifestation of COVID-19 infection R. Merhy, A.S Sarkis, F. Stephan
331 [GO] 2020―Nov―21 Adverse skin reactions following different types of mask usage during the COVID-19 pandemic Chayada Chaiyabutr, Thanisorn Sukakul, Chutipon Pruksaeakanan, Janista Thumrongtharadol Waranya Boonchai
332 [GO] 2020―Nov―21 Impact of the COVID-19 Pandemic on Inpatient Dermatology: A Multicenter Study from Hubei, China Yamin Zhang, Jingjing Wen, Mahin Alamgir, Jun Xie, Haixia Jing, Muping Fang, et al. (+5)
333 [GO] 2020―Nov―21 SARS-CoV-2-induced telogen effluvium: a multicentric study O.M. Moreno-Arrones, A. Lobato-Berezo, A. Gomez-Zubiaur, S. Arias-Santiago, D. Saceda-Corralo, C. Bernardez-Guerra, et al. (+9)
334 [GO] 2020―Nov―02 Self-reported cutaneous manifestations in 1,429 Brazilian COVID-19 patients Hélio Amante Miot, Mayra Ianhez, Paulo Müller Ramos
335 [GO] 2020―Nov―02 5-Alpha-Reductase Inhibitors are Associated with Reduced Frequency of COVID-19 Symptoms in Males with Androgenetic Alopecia John McCoy, Flávio Adsuara Cadegiani, Carlos Gustavo Wambier, Sabina Herrera, Sergio Vaño-Galván, Natasha Atanaskova Mesinkovska, et al. (+5)
336 [GO] 2020―Nov―01 COVID-19 in patients with cutaneous immune-mediated diseases in The Netherlands: real-world observational data L.E.M. de Wijs, M.M. Joustra, J.I. Olydam, T. Nijsten, D.J. Hijnen
337 [GO] 2020―Oct―22 Clinical Symptoms of Hyperandrogenic Women Diagnosed with COVID-19 FA Cadegiani, RK Lim, A Goren, J McCoy, M Situm, M Kovacevic, et al. (+4)
338 [GO] 2020―Oct―22 Are SARS-CoV-2 IgA antibodies in paediatric patients with chilblain-like lesions indicative of COVID-19 asymptomatic or paucisymptomatic infection? A. Diociaiuti, S. Giancristoforo, S. Terreri, M. Corbeddu, C. Concato, M. Ciofi Degli Atti, et al. (+3)
339 [GO] 2020―Oct―20 A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic K. Hansel, A. Zangrilli, L. Bianchi, K. Peris, A. Chiricozzi, A. Offidani, et al. (+7)
340 [GO] 2020―Oct―20 Increase in sexually transmitted infection during the COVID-19 pandemic in Taiwan Kun-Kuang Lee, Chih-Cheng Lai, Chien-Ming Chao, Hung-Jen Tang
341 [GO] 2020―Oct―12 Diagnosis of hair disorders during the COVID-19 pandemic: An introduction to teletrichoscopy M. Randolph, A. Al-alola, A. Tosti
342 [GO] 2020―Oct―03 Why are chilblains underreported in Nordic countries during the COVID-19 pandemic? An analysis of Google trends Nicolas Kluger
343 [GO] 2020―Oct―03 Immunological and virological profile of children with chilblain-like lesions and SARS-CoV-2 L. Fertitta, A. Welfringer, A. Ouedrani, L. Polivka, S. Chhun, L. Chatenoud, et al. (+5)
344 [GO] 2020―Oct―01 SARS-CoV-2 spike protein is present in both endothelial and eccrine cells of a chilblain-like skin lesion T. Gambichler, J. Reuther, M. Stücker, R. Stranzenbach, C. Torres-Reyes, R. Schlottmann, et al. (+4)
345 [GO] 2020―Sep―27 “Occupational dermatoses from Personal Protective Equipment during the COVID-19 pandemic in the tropics - A Review” HC Lee, CL Goh
346 [GO] 2020―Sep―26 Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men Andy Goren, Carlos Gustavo Wambier, Sabina Herrera, John McCoy, Sergio Vaño-Galván, Francesca Gioia, et al. (+9)
347 [GO] 2020―Sep―25 Androgen Receptor Genetic Variant Predicts COVID-19 Disease Severity: A Prospective Longitudinal Study of Hospitalized COVID-19 Male Patients John McCoy, Carlos Gustavo Wambier, Sabina Herrera, Sergio Vaño-Galván, Francesca Gioia, Belen Comeche, et al. (+9)
348 [GO] 2020―Sep―24 Comment on “Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19”: Involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID-19 Tetsuo Shiohara, Yoshiko Mizukawa
349 [GO] 2020―Sep―01 Cutaneous Symptoms of Patients Diagnosed with Covid-19 in One Province: A Cross-Sectional Survey Eda Öksüm Solak, Burcu Baran Ketencioglu, Hümeyra Aslaner, Salih Levent Çinar, Demet Kartal, Ali Ramazan Benli, Murat Borlu
350 [GO] 2020―Sep―01 Frequent hand washing and disinfection-a potential new trigger for aquagenic wrinkling of the palms caused by COVID-19 outbreak Yukimasa Tai, Takeshi Fukumoto, Masahiro Oka, Chikako Nishigori
351 [GO] 2020―Sep―01 How the use of surgical masks during COVID-19 pandemic can induce skin effects S. Veronese, P. Bernardi, A. Sbarbati
352 [GO] 2020―Sep―01 Generalized Pustular Figurate Erythema. First Report in Two COVID-19 Patients on Hydroxychloroquine I. Abadías-Granado, A.M. Palma-Ruiz, P.A. Cerro, A.M. Morales-Callaghan, M.C. Gómez-Mateo, Y. Gilaberte, R.A. Schwartz
353 [GO] 2020―Sep―01 Skin manifestations in COVID-19 provide a clue for disease’s pathophysiology understanding AA Kubanov, DG Deryabin
354 [GO] 2020―Aug―31 Chilblains and COVID-19: further evidence against a causal association Marie Baeck, Caroline Peeters, Anne Herman
355 [GO] 2020―Aug―27 Toxic epidermal necrolysis and co-existent SARS-CoV-2 (COVID-19) treated with Intravenous Immunoglobulin: “ Killing 2 birds with one ston e” M. Saha, A. D’Cruz, N. Paul, R. Healy, D. Collins, D-A. Charles, et al. (+2)
356 [GO] 2020―Aug―27 COVID-19-related cutaneous manifestations associated with multiple drug sensitization as shown by lymphocyte transformation test Jun Hayakawa, Hiroki Takakura, Yoshiko Mizukawa, Tetsuo Shiohara
357 [GO] 2020―Aug―27 Scabies outbreak during home confinement due to the SARS-CoV-2 pandemic Isabel Martínez-Pallás, Beatriz Aldea-Manrique, Mar Ramírez-Lluch, José Manuel Vinuesa-Hernando, Mariano Ara-Martín
358 [GO] 2020―Aug―27 Acral skin eruption observed during SARS-CoV-2 pandemic: possible keratolysis exfoliativa with red palms and soles Iria Neri, Annalisa Patrizi, Liliana Gabrielli, Annalucia Virdi, Giulia Veronesi, Ilaria Corsini, et al. (+4)
359 [GO] 2020―Aug―13 Recommendations for skin cancer consultation and surgery during COVID-19 pandemic L. Brochez, J.F. Baurain, V. Del Marmol, A. Nikkels, V. Kruse, F. Sales, et al. (+3)
360 [GO] 2020―Aug―12 Delayed melanoma diagnosis in the COVID-19 era: Increased breslow thickness in primary melanomas seen after the COVID-19 lockdown F. Ricci, L. Fania, A. Paradisi, G. Di Lella, S. Pallotta, L. Sobrino, et al. (+3)
361 [GO] 2020―Aug―12 Severe COVID-19 outcomes in patients with psoriasis X.T. Lima, M.A. Cueva, E.M Lopes, M.B. Alora
362 [GO] 2020―Aug―12 Concerns related to the COVID-19 pandemic in adult patients with atopic dermatitis and psoriasis treated with systemic immunomodulatory therapy: a Danish questionnaire survey Nikolai Dyrberg Loft, Anne-Sofie Halling, Lars Iversen, Christian Vestergaard, Mette Deleuran, Mads Kirchheiner Rasmussen, et al. (+3)
363 [GO] 2020―Aug―03 A survey on teledermatology (td) use and doctors’ perception in times of COVID-19 Elvira Moscarella, Paola Pasquali, Elisa Cinotti, Linda Tognetti, Giuseppe Argenziano, Pietro Rubegni
364 [GO] 2020―Jul―31 Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19 Anne Herman, Marine Matthews, Margaux Mairlot, Laura Nobile, Laetiia Fameree, Luc-Marie Jacquet, Marie Baeck
365 [GO] 2020―Jul―31 Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy M Talamonti, M Galluzzo, A Chiricozzi, P Quaglino, G Fabbrocini, P Gisondi, et al. (+64)
366 [GO] 2020―Jul―17 The skin in the era of coronavirus pandemic J. Ring
367 [GO] 2020―Jul―11 STIs and the COVID-19 pandemic: the lockdown does not stop sexual infections R. Balestri, M. Magnano, L. Rizzoli, S.D. Infusino, F. Urbani, G. Rech
368 [GO] 2020―Jul―03 Concurrent chilblains and retinal vasculitis in a child with COVID-19 Lucía Quintana-Castanedo, Marta Feito-Rodríguez, Celia Fernández-Alcalde, María Granados-Fernández, Dolores Montero-Vega, Ander Mayor-Ibarguren, Raúl de Lucas-Laguna
369 [GO] 2020―Jul―03 Dermoscopy features of COVID-19-related chilblains in children and adolescents Lourdes Navarro, David Andina, Lucero Noguera-Morel, Angela Hernández-Martín, Isabel Colmenero, Antonio Torrelo
370 [GO] 2020―Jun―28 COVID-19 and cutaneous manifestations: A systematic review Qing Zhao, Xiaokai Fang, Zheng Pang, Bowen Zhang, Hong Liu, Furen Zhang
371 [GO] 2020―Jun―28 COVID-19 and outbreak of chilblains: are they related? C. Lesort, J. Kanitakis, A. Villani, E. Ducroux, P. Bouschon, K. Fattouh, et al. (+3)
372 [GO] 2020―Jun―28 Prior treatment with immunosuppressants among COVID-19 inpatients at one hospital in Spain MA Pastor-Nieto, P Checa-Díaz, P González-Muñoz, A Martín-Fuentes, A Vergara-Sánchez, C Sánchez-Herreros, et al. (+8)
373 [GO] 2020―Jun―28 COVID-19 Lockdown induced acral dermatosis in children Nathalie Bodak, Christine Chiaverini, Sebastien Barbarot
374 [GO] 2020―Jun―28 Compliance, safety concerns and anxiety in patients treated with biologics for psoriasis during the COVID-19 pandemic national lockdown: A multicenter study in the Czech Republic F Rob, J Hugo, S Tivadar, P Boháč, S Gkalpakiotis, N Vargová, et al. (+2)
375 [GO] 2020―Jun―27 Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature S. Matar, B. Oulès, P. Sohier, O. Chosidow, M. Beylot-Barry, N. Dupin, S. Aractingi
376 [GO] 2020―Jun―27 Acute acral cutaneous manifestations during the COVID-19 pandemic: a single center experience Marta García-Legaz Martínez, Álvaro Martínez-Doménech, Jorge Magdaleno-Tapial, Cristian Valenzuela-Oñate, Felipe Partarrieu-Mejías, Javier Lorca-Spröhnle, et al. (+3)
377 [GO] 2020―Jun―27 Recent outbreak of chilblain-like lesions is not directly related with SARS-CoV-2 infection J. Rouanet, E. Lang, F. Beltzung, B. Evrard, C. Henquell, I. Joulie, M. D’Incan
378 [GO] 2020―Jun―26 Relapsing symmetric livedo reticularis in a patient with COVID-19 infection M. Verheyden, M. Grosber, J. Gutermuth, B. Velkeniers
379 [GO] 2020―Jun―25 Cutaneous manifestations of SARS-CoV-2 infection: a clinical update P Gisondi, S PIaserico, C Bordin, M Alaibac, G Girolomoni, L Naldi
380 [GO] 2020―Jun―21 Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19 Anne-Claire Fougerousse, Marc Perrussel, Pierre-André Bécherel, Edouard Begon, Valérie Pallure, Ines Zaraa, et al. (+8)
381 [GO] 2020―Jun―19 ‘’Treatment adherence in psoriatic patients during COVID-19 pandemic: Real-world data from a tertiary hospital in Greece’’ Authors: E Vakirlis, K Bakirtzi, I Papadimitriou, F Vrani, N Sideris, A Lallas, et al. (+2)
382 [GO] 2020―Jun―19 An unusual case of bullous hemorrhagic vasculitis in a COVID-19 patient S. Negrini, A. Guadagno, M. Greco, A. Parodi, M. Burlando
383 [GO] 2020―Jun―18 Catastrophic acute bilateral lower limbs necrosis associated with COVID-19 as a likely consequence of both vasculitis and coagulopathy P Del Giudice, D Boudoumi, B Le Guen, M Reverte, J Gutnecht, JP Lacour, et al. (+3)
384 [GO] 2020―Jun―18 Cutaneous involvement during COVID-19 pandemic: an emerging sign of infection Maria Carmela Annunziata, Angela Patrì, Angelo Ruggiero, Adriana Di Guida, Claudia Menicanti, Vincenzo Greco, Gabriella Fabbrocini
385 [GO] 2020―Jun―16 Symmetric chest pressure ulcers, consequence of prone position ventilation in a patient with COVID-19 N Martínez Campayo, JI Bugallo Sanz, I Mosquera Fajardo
386 [GO] 2020―Jun―14 Occupational skin disease during the COVID-19 pandemic, as captured in a Dermatology staff clinic in the United Kingdom Sofia Hadjieconomou, Jenny Hughes, Sandeep Kamath
387 [GO] 2020―Jun―14 The red half moon nail sign: a novel manifestation of Coronavirus infection Iria Neri, Alba Guglielmo, Annalucia Virdi, Valeria Gaspari, Michela Starace, Bianca Maria Piraccini
388 [GO] 2020―Jun―14 SARS-CoV-2, skin lesions and the need of a multidisciplinary approach R. Cabrera-Hernández, E. Solano-Solares, V. Chica-Guzmán, M. Fernández-Guarino, D. Fernández-Nieto, D. Ortega-Quijano, et al. (+6)
389 [GO] 2020―Jun―13 Major cluster of pediatric “ true ” primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown Neri Iria, Virdi Annalucia, Corsini Ilaria, Guglielmo Alba, Lazzarotto Tiziana, Gabrielli Liliana, et al. (+3)
390 [GO] 2020―Jun―13 Cutaneous manifestations of hospitalized COVID-19 patients: A report of six cases with clinicopathologic features and viral RNA in situ hybridization C. Bitar, M.P. Chan, P.W. Harms, D.R. Fullen, J.E. Gudjonsson, M. Eshaq, et al. (+7)
391 [GO] 2020―Jun―13 Teledermatology for acne during COVID-19: high patients’ satisfaction in spite of the emergency Angelo Ruggiero, Matteo Megna, Maria Carmela Annunziata, Luisa Abategiovanni, Massimiliano Scalvenzi, Andrea Tajani, et al. (+2)
392 [GO] 2020―Jun―13 Cutaneous autoimmune diseases during COVID 19 pandemic C Günther, R Aschoff, S Beissert
393 [GO] 2020―Jun―12 A generalized purpuric eruption with histopathologic features of leucocytoclastic vasculitis in a patient severely ill with COVID-19 V. Caputo, J. Schroeder, F. Rongioletti
394 [GO] 2020―Jun―12 Two cases of cutaneous eruptions due to CoVID-19 infection in Singapore: New insights into the spectrum of clinical presentation and histopathology Benjamin Wen Yang Ho, Dingyuan Wang, Llewelyn Yi Chang Tan, Manish Mahadeorao Bundele, Chee Hian Tan, Joel Hua-Liang Lim
395 [GO] 2020―Jun―12 Papular-Purpuric Exanthem in a COVID-19 Patient: Clinical and Dermoscopic Description J. Larrondo, R. Cabrera, M. Gosch, F. Larrondo, M. Aylwin, A. Castro
396 [GO] 2020―Jun―11 The broad spectrum of dermatological manifestations in COVID-19. Clinical and histopathological features learned from a series of 34 cases C.A. Rubio-Muniz, M. Puerta-Peña, D. Falkenhain-López, J. Arroyo-Andrés, M. Agud-Dios, J.L. Rodriguez-Peralto, et al. (+2)
397 [GO] 2020―Jun―11 SARS-CoV, Mers-CoV and Covid-19:what differences from a dermatological viewpoint? Franco Rongioletti
398 [GO] 2020―Jun―08 Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom? D. de Perosanz-Lobo, D. Fernandez-Nieto, P. Burgos-Blasco, G. Selda-Enriquez, I. Carretero, C. Moreno, M. Fernández-Guarino
399 [GO] 2020―Jun―05 Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not “varicella-like” A. Mahé, E. Birckel, C. Merklen, P. Lefèbvre, C. Hannedouche, M. Jost, L. Droy-Dupré
400 [GO] 2020―Jun―04 Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID-19 pandemic PV Chernyshov, L Tomas-Aragones, M Augustin, A Svensson, A Bewley, F Poot, et al. (+14)
401 [GO] 2020―Jun―04 Exanthema and eosinophilia in Covid-19 patients: has viral infection a role in drug induced exanthemas? AM Rosell-Díaz, A Mateos-Mayo, LM Nieto-Benito, I Balaguer-Franch, E Hernández de, A Laínez-Nuez, et al. (+2)
402 [GO] 2020―Jun―04 Eosinophilic granulomatosis with polyangiitis mimicking COVID-19: a case report H. Hashizume, Y. Sano, S. Furukawa, S. Imokawa
403 [GO] 2020―Jun―04 Iatrogenic dermatitis in times of COVID-19: A pandemic within a pandemic Riti Bhatia, Tekumalla Sindhuja, Saurabh Bhatia, Tanvi Dev, Atula Gupta, Meenu Bajpai, Somesh Gupta
404 [GO] 2020―Jun―04 Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients. A Reymundo, A Fernáldez-Bernáldez, A Reolid, B Butrón, P Fernández-Rico, P Muñoz-Hernández, et al. (+2)
405 [GO] 2020―Jun―03 No antibody response in acral cutaneous manifestations associated with COVID-19 ? Rafael Mahieu, Lila Tillard, Hélène Le Guillou-Guillemette, Emeline Vinatier, Pascale Jeannin, Anne Croué, et al. (+2)
406 [GO] 2020―Jun―03 Retiform purpura as a dermatological sign of covid-19 coagulopathy X Bosch-Amate, P Giavedoni, S Podlipnik, C Andreu-Febrer, J Sanz-Beltran, A Garcia-Herrera, et al. (+2)
407 [GO] 2020―Jun―03 Pitfalls of possible reporting of same patients with COVID-19 in dermatology journals Nicolas Kluger
408 [GO] 2020―Jun―03 Acro-ischemia and COVID-19 infection: clinical and histopathological features J Calvão, M Relvas, A Pinho, A Brinca, J.C. Cardoso
409 [GO] 2020―Jun―03 Sexually Transmitted Infections during the COVID-19 outbreak: comparison of patients referring to the service of sexually transmitted diseases during the sanitary emergency with those referring during the common practice L. Sacchelli, F. Viviani, G. Orioni, P. Rucci, S. Rosa, A. Lanzoni, et al. (+2)
410 [GO] 2020―Jun―03 COVID-19: how it can look on the skin. Clinical and pathological features in twenty COVID-19 patients observed in Bologna, northeastern Italy Valeria Gaspari, Iria Neri, Cosimo Misciali, Annalisa Patrizi
411 [GO] 2020―Jun―03 Hand Eczema Pandemic Caused by SARS-CoV-2 Hygiene Measures: The Setup of a Hand Eczema Helpline for Hospital Personnel K. Greveling, A.C.M. Kunkeler
412 [GO] 2020―Jun―03 Retroauricular dermatitis with vehement use of ear loop face masks during COVID19 pandemic Atul Bothra, Seujee Das, Mehak Singh, Manoj Pawar, Anshu Maheswari
413 [GO] 2020―May―31 A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection M. El Hachem, A. Diociaiuti, C. Concato, R. Carsetti, C. Carnevale, M. Ciofi Degli Atti, et al. (+9)
414 [GO] 2020―May―26 Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19) M. Dominguez-Santas, B. Diaz-Guimaraens, P. Garcia Abellas, C. Moreno-Garcia del Real, P. Burgos-Blasco, A. Suarez-Valle
415 [GO] 2020―May―26 COVID-19 in a melanoma patient under treatment with checkpoint inhibition P. Schmidle, T. Biedermann, C. Posch
416 [GO] 2020―May―26 Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children P. Labé, A. Ly, C. Sin, M. Nasser, E. Chapelon-Fromont, P. Ben Saïd, E. Mahé
417 [GO] 2020―May―26 The COVID-19 outbreak in dermatologic surgery: resetting clinical priorities E. Rossi, M. Trakatelli, L. Giacomelli, B. Ferrari, M. Francomano, G. Pellacani, C. Magnoni
418 [GO] 2020―May―26 A case of cefditoren-induced acute generalized exanthematous pustulosis during COVID-19 pandemics. Severe cutaneous adverse reactions are an issue I. Torres-Navarro, C. Abril-Pérez, J. Roca-Ginés, J. Sánchez-Arráez, R. Botella-Estrada
419 [GO] 2020―May―26 Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review A. Docampo-Simón, M.J. Sánchez-Pujol, G. Juan-Carpena, J.C. Palazón-Cabanes, E. Vergara-De Caso, L. Berbegal, et al. (+9)
420 [GO] 2020―May―26 Coronavirus 19 presenting with atypical Sweet's syndrome B. Taşkın, S. Vural, E. Altuğ, C. Demirkesen, E. Kocatürk, İ. Çelebi, et al. (+2)
421 [GO] 2020―May―26 Late onset of acral necrosis after SARS-CoV-2 infection resolution R. Balestri, S. Termine, G. Rech, C.R. Girardelli
422 [GO] 2020―May―22 Diversity of clinical appearance of cutaneous manifestations in the course of COVID-19 C. Guarneri, E. Venanzi Rullo, R. Gallizzi, M. Ceccarelli, S.P. Cannavò, G. Nunnari
423 [GO] 2020―May―22 COVID-19 and its implications for Dermatology and Venereology J. Ring
424 [GO] 2020―May―22 Cutaneous small vessel vasculitis secondary to COVID-19 infection: A case report A Mayor-Ibarguren, M Feito-Rodriguez, L Quintana Castanedo, E Ruiz-Bravo, D Montero Vega, P Herranz-Pinto
425 [GO] 2020―May―22 Protecting medical staff from skin injury/disease caused by personal protective equipment during epidemic period of COVID-19: experience from China H. Long, H. Zhao, A. Chen, Z. Yao, B. Cheng, Q. Lu
426 [GO] 2020―May―20 Acral purpuric lesions (Erythema multiforme type) associated with thrombotic vasculopathy in a child during the COVID-19 pandemic MF García-Gil, M García García, J Monte Serrano, L Prieto-Torres, M Ara-Martín
427 [GO] 2020―May―19 COVID-19 and Dermatology: A Comprehensive Guide for Dermatologists Dina Hassan Fahmy, Heba Saed El-Amawy, Marwa Ahmed El-Samongy, Aya Ashraf Foud, Sarah Hamdy Soliman, Aya El-Kady, et al. (+9)
428 [GO] 2020―May―19 Metastatic melanoma treatment with check point inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit Pietro Quaglino, Paolo Fava, Matteo Brizio, Elena Marra, Marco Rubatto, Andrea Agostini, et al. (+3)
429 [GO] 2020―May―19 A clinicopathological study of 8 patients with COVID-19 pneumonia and a late-onset exanthema M Herrero-Moyano, TM Capusan, M Andreu-Barasoain, J Alcántara-González, M Ruano-Del Salado, ME Sánchez-Largo Uceda, et al. (+2)
430 [GO] 2020―May―19 Fever with Rash in COVID-19: Viral Exanthema or Secondary Lesions? M Goldust, A Abdelmaksoud, Z Shuang, C Xiang, AA Navarini
431 [GO] 2020―May―18 Teledermatology for COVID-19 cutaneous lesions: substitute or supplement? C Skayem, C Cassius, M Ben Kahla, C Fiani, L Frumholtz, M Mrad, et al. (+5)
432 [GO] 2020―May―18 A late onset widespread skin rash in a previous Covid-19 infected patient: viral or multidrug effect? N. Skroza, N. Bernardini, V. Balduzzi, A. Mambrin, A. Marchesiello, S. Michelini, et al. (+5)
433 [GO] 2020―May―18 Efficacy of hydrogel patches in preventing facial skin damage caused by mask compression in fighting against coronavirus disease-2019: a short-term, self-controlled study Liyun Dong, Liu Yang, Yan Li, Jing Yang, Xiangjie An, Liu Yang, et al. (+8)
434 [GO] 2020―May―16 Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines Maarten Vermeer Evangelia Papadavid, Julia Scaribrick, Pablo Ortiz Romero, Pietro Guaglino, Maarten Vermeer, Robert Knobler, et al. (+2)
435 [GO] 2020―May―12 Personal protective equipment induced facial dermatoses in healthcare workers managing COVID-19 cases Mehak Singh, Manoj Pawar, Atul Bothra, Anshu Maheshwari, Vivek Dubey, Apoorv Tiwari, Awatef Kelati
436 [GO] 2020―May―09 Dermatologic Surgery Training during the COVID-19 era José Alberto García-Lozano, Adrian Cuellar-Barboza, Verónica Garza-Rodríguez, Osvaldo Vázquez-Martínez, Jorge Ocampo-Candiani
437 [GO] 2020―May―09 Reply to “Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection”: Urticaria-like lesions in COVID-19 patients are not really urticaria. A case with clinicopathologic correlation Pedro Rodríguez-Jiménez, Pablo Chicharro, Diego De Argila, Patricia Muñoz-Hernández, Mar Llamas-Velasco
438 [GO] 2020―May―09 Urticarial eruption in Coronavirus Disease 2019 (COVID-19) infection: a case report in Tangerang, Indonesia Catherine Gunawan, Allen Widysanto
439 [GO] 2020―May―09 Localised mid-face miliaria as a consequence of filtering face piece (FFP) respirator use during the COVID-19 pandemic V Campbell, D Middleton, J Donnelly, H Hunter
440 [GO] 2020―May―09 Histologic features of long lasting chilblain-like lesions in a pediatric COVID-19 patient A.G. Locatelli, E. Robustelli Test, P. Vezzoli, A. Carugno, E. Moggio, L. Consonni, et al. (+2)
441 [GO] 2020―May―09 “Toxic erythema” and eosinophilia associated to tocilizumab therapy in a COVID-19 patient A Sernicola, G Carnicelli, M Di Fraia, C Chello, C Furlan, R Muharremi, et al. (+2)
442 [GO] 2020―May―09 COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management Cristina Mugheddu, Laura Pizzatti, Silvia Sanna, Laura Atzori, Franco Rongioletti
443 [GO] 2020―May―09 Acute Generalized Exanthematous Pustulosis with Erythema Multiforme-Like lesions in a COVID-19 woman E. Robustelli Test, P. Vezzoli, A. Carugno, F. Raponi, A. Gianatti, F. Rongioletti, P. Sena
444 [GO] 2020―May―09 Atypical erythema multiforme palmar plaques lesions due to Sars-Cov-2 Hicham Janah, Ali Zinebi, Jalal Elbenaye
445 [GO] 2020―May―09 SARS-CoV-2 asymptomatic infection in a patient under treatment with dupilumab Francesca Caroppo, Giulia Biolo, Anna Belloni Fortina
446 [GO] 2020―May―07 Drug-induced vasculitis in a patient with COVID-19 A. Vanegas Ramirez, D. Efe, M. Fischer
447 [GO] 2020―May―07 Evolution of COVID-19 infection in 4 psoriatic patients treated with biological drugs A. Conti, C. Lasagni, L. Bigi, G. Pellacani
448 [GO] 2020―May―07 Acro-ischemia in hospitalized COVID-19 patients A. Suarez-Valle, D. Fernandez-Nieto, B. Diaz-Guimaraens, M. Dominguez-Santas, I. Carretero, B. Perez-Garcia
449 [GO] 2020―May―07 Symmetric cutaneous vasculitis in COVID-19 pneumonia Laura Castelnovo, Francesca Capelli, Antonio Tamburello, Paola Maria Faggioli, Antonino Mazzone
450 [GO] 2020―May―07 SARS-CoV-2 possible contamination of genital area: implications for sexual and vertical transmission routes M Delfino, M Guida, A Patrì, L Spirito, L Gallo, G Fabbrocini
451 [GO] 2020―May―07 Improvement of SARS-CoV2 symptoms following Guselkumab injection in a psoriatic patient F. Benhadou, V. Del Marmol
452 [GO] 2020―May―03 Hand disinfection in the combat against Covid-19 M Goldust, A Abdelmaksoud, AA Navarini
453 [GO] 2020―May―03 Estimated effect of COVID-19 lockdown on melanoma thickness and prognosis: a rate of growth model Antonio Tejera-Vaquerizo, Eduardo Nagore
454 [GO] 2020―May―03 Occupational skin conditions on the frontline: A survey among 484 Chinese healthcare professionals caring for Covid-19 patients Shiyao Pei, Yadong Xue, Shuang Zhao, Navarini Alexander, Goldust Mohamad, Xiang Chen, Mingzhu Yin
455 [GO] 2020―May―02 COVID-19 epidemic: Skin protection for health care workers must not be ignored Bin Zhang, Ruijie Zhai, Lin Ma
456 [GO] 2020―May―02 Histological pattern in Covid-19 induced viral rash Corrado Zengarini, Gionathan Orioni, Alessandra Cascavilla, Clara Horna Solera, Ciro Fulgaro, Cosimo Misciali, et al. (+2)
457 [GO] 2020―May―02 Pityriasis rosea as a cutaneous manifestation of COVID-19 infection Amir Hooshang Ehsani, Maryam Nasimi, Zeinab Bigdelo
458 [GO] 2020―May―02 The use of Google trends for acral symptoms during COVID-19 outbreak in France Nicolas Kluger, Yannis Scrivener
459 [GO] 2020―May―02 Occurrence of SARS-CoV-2 during mycophenolate mofetil treatment for pemphigus R. Balestri, G. Rech, C.R. Girardelli
460 [GO] 2020―May―02 SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor R. Balestri, G. Rech, C.R. Girardelli
461 [GO] 2020―May―01 European Task Force on Contact Dermatitis statement on coronavirus 19 disease (COVID-19) outbreak and the risk of adverse cutaneous reactions Anna Balato, Fabio Ayala, Magnus Bruze, Marie-Noëlle Crepy, Margarida Gonçalo, Jeanne Duus Johansen, et al. (+10)
462 [GO] 2020―Apr―27 No evidence of increased risk for COVID-19 infection in patients treated with Dupilumab for atopic dermatitis in a high-epidemic area - Bergamo, Lombardy, Italy A. Carugno, F. Raponi, A.G. Locatelli, P. Vezzoli, D.M. Gambini, M. Di Mercurio, et al. (+2)
463 [GO] 2020―Apr―27 Vascular skin symptoms in COVID-19: a french observational study JD Bouaziz, T Duong, M Jachiet, C Velter, P Lestang, C Cassius, et al. (+6)
464 [GO] 2020―Apr―25 Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic M. Kasperkiewicz, E. Schmidt, J.A. Fairley, P. Joly, A.S. Payne, M.L. Yale, et al. (+2)
465 [GO] 2020―Apr―25 Skin cancer triage and management during COVID-19 pandemic Luca Tagliaferri, Alessandro Di Stefani, Giovanni Schinzari, Bruno Fionda, Ernesto Rossi, Laura Del Regno, et al. (+5)
466 [GO] 2020―Apr―24 Acral cutaneous lesions in the Time of COVID-19 S. Recalcati, T. Barbagallo, L.A. Frasin, F. Prestinari, A. Cogliardi, M.C. Provero, et al. (+3)
467 [GO] 2020―Apr―24 Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients Vincenzo Piccolo, Iria Neri, Cesare Filippeschi, Teresa Oranges, Giuseppe Argenziano, Vincenzo Claudio Battarra, et al. (+9)
468 [GO] 2020―Apr―24 Cutaneous manifestation of COVID-19 in images: A case report R. Avellana Moreno, Estela Villa, V. Avellana Moreno, C. Estela Villa, Moreno Aparicio, Avellana Fontanella
469 [GO] 2020―Apr―24 Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection C. van Damme, E. Berlingin, S. Saussez, O. Accaputo
470 [GO] 2020―Apr―24 Did Whatsapp ® reveal a new cutaneous COVID-19 manifestation? TA Duong, C Velter, M Rybojad, C Comte, M Bagot, L Sulimovic, JD Bouaziz
471 [GO] 2020―Apr―24 Mass quarantine measures in the time of COVID-19 pandemic: psycho-social implications for chronic skin conditions and a call for qualitative studies S. Garcovich, F.S Bersani, A. Chiricozzi, C. De Simone
472 [GO] 2020―Apr―24 Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome A. Tammaro, G.A.R. Adebanjo, F.R. Parisella, A. Pezzuto, J. Rello
473 [GO] 2020―Apr―24 Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports S. Ferrucci, M. Romagnuolo, L. Angileri, E. Berti, S. Tavecchio
474 [GO] 2020―Apr―24 SARS-CoV-2 infection presenting as a febrile rash F Amatore, N Macagno, M Mailhe, B Demarez, C Gaudy-Marqueste, JJ Grob, et al. (+3)
475 [GO] 2020―Apr―22 Dermatologists and SARS-CoV-2: The impact of the pandemic on daily practice P Gisondi, S Piaserico, A Conti, L Naldi
476 [GO] 2020―Apr―21 Comment on “Cutaneous manifestations in COVID-19: a first perspective ” by Recalcati S M. Hedou, F. Carsuzaa, E. Chary, E. Hainaut, F. Cazenave-Roblot, M. Masson Regnault
477 [GO] 2020―Apr―17 Skin Reactions to Non-glove Personal Protective Equipment: An Emerging Issue in the COVID-19 Pandemic Mehdi Gheisari, Farnaz Araghi, Hamideh Moravvej, Mohammadreza Tabary, Sahar Dadkhahfar
478 [GO] 2020―Apr―17 Covid-19: Countermeasure for N95 mask-induced pressure sore ZhiQiang Yin
479 [GO] 2020―Apr―17 Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases? Ambra Di Altobrando, Annalisa Patrizi, Federico Bardazzi
480 [GO] 2020―Apr―15 Viral exanthem in COVID-19, a clinical enigma with biological significance Chia-Jui Su, Chih-Hung Lee
481 [GO] 2020―Apr―15 COVID-19 and Cutaneous manifestations Rujittika Mungmungpuntipantip, Viroj Wiwanitkit
482 [GO] 2020―Apr―15 Face the COVID-19 emergency: measures applied in an Italian Dermatologic Clinic C. Marasca, A. Ruggiero, M.C. Annunziata, G. Fabbrocini, M. Megna
483 [GO] 2020―Apr―15 Urticarial eruption in COVID-19 infection D. Henry, M. Ackerman, E. Sancelme, A. Finon, E. Esteve
484 [GO] 2020―Apr―15 Comment on: Cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies D Fernandez-Nieto, D Ortega-Quijano, G Segurado-Miravalles, C Pindado-Ortega, M Prieto-Barrios, J Jimenez-Cauhe
485 [GO] 2020―Apr―15 Cutaneous manifestations in COVID-19: a new contribution Andrea Estébanez, Leticia Pérez-Santiago, Esmeralda Silva, Santiago Guillen-Climent, Alejandro García-Vázquez, M. Dolores Ramón
486 [GO] 2020―Apr―15 A distinctive skin rash associated with Coronavirus Disease 2019 ? A. Mahé, E. Birckel, S. Krieger, C. Merklen, L. Bottlaender
487 [GO] 2020―Apr―15 Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in sardinia (Italy) L. Atzori, C. Mugheddu, G. Addis, S. Sanna, R. Satta, C. Ferreli, et al. (+3)
488 [GO] 2020―Apr―15 SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor F. Messina, S. Piaserico
489 [GO] 2020―Mar―29 Art of performing dermoscopy during the times of coronavirus disease (COVID-19): Simple change in approach can save the day! Deepak Jakhar, Ishmeet Kaur, Subuhi Kaul
490 [GO] 2020―Mar―29 European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-infection and atopic dermatitis Andreas Wollenberg, Carsten Flohr, Dagmar Simon, Michael J Cork, Jacob P. Thyssen, Thomas Bieber, et al. (+27)
491 [GO] 2020―Mar―27 What dermatologists could do to cope with the novel coronavirus (SARS-CoV-2): a dermatologist’s perspective from China Hanlin Zhang, Keyun Tang, Rouyu Fang, Qiuning Sun
492 [GO] 2020―Mar―27 Medical education and care in dermatology during the SARS-CoV2 pandemia: challenges and chances M Reinholz, LE French
493 [GO] 2020―Mar―26 Cutaneous manifestations in COVID-19: a first perspective S. Recalcati
494 [GO] 2020―Mar―23 Dermatology staff participate in fight against Covid-19 in China Yue Zheng, Wei Lai
495 [GO] 2020―Mar―23 Global coronavirus pandemic (2019-nCOV): Implication for an Italian medium size dermatological clinic of a ii level hospital G. Radi, F. Diotallevi, A. Campanati, A. Offidani
 [1] 

495 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.012 sec